Abstracts | 0095 | ESPE2022 | 60th Annual ESPE (ESPE 2022)

Scientific Programme, ePosters & Abstracts

Previous issue | Volume 95 | ESPE2022 | Next issue

60th Annual ESPE (ESPE 2022)

Rome, Italy
15 Sep 2022 - 17 Sep 2022

The 60th ESPE Annual Meeting will now be taking place in Rome, Italy.

Plenary Lectures
- Copeptin in Vasopressin-dependent fluid disorders
- - Copeptin in vasopressin-dependent fluid disorders
    
    hrp0095pl1
- Prevention of T1D “in children
- - Abstract unavailable
    
    hrp0095pl2
- Potentialities of gene therapy in Paediatric Endocrinology
- - Abstract unavailable
    
    hrp0095pl3
- Nutritional control of Growth and Puberty
- - Abstract unavailable
    
    hrp0095pl4
- Precision medicine in Diabetes
- - Abstract unavailable
    
    hrp0095pl5
- Growth: Genetic determinates of height
- - Abstract unavailable
    
    hrp0095pl6
- How science can benefit from philosophy
- - Why science needs philosophy and vice-versa
    
    hrp0095pl7
- Novel Advances in Obesity
- - Abstract unavailable
    
    hrp0095pl8
Symposia
- Novel insights into adrenal insufficiency
- - Abstract unavailable
    
    hrp0095s1.1
  - Abstract unavailable
    
    hrp0095s1.2
  - Abstract unavailable
    
    hrp0095s1.3
- HPG
- - Abstract unavailable
    
    hrp0095s2.1
  - Abstract unavailable
    
    hrp0095s2.2
  - Abstract unavailable
    
    hrp0095s2.3
- All around Beta cells - the problem and future solutions
- - Abstract unavailable
    
    hrp0095s3.1
  - Abstract unavailable
    
    hrp0095s3.2
  - Abstract unavailable
    
    hrp0095s3.3
- Regulation of growth
- - Abstract unavailable
    
    hrp0095s4.1
  - Abstract unavailable
    
    hrp0095s4.2
  - Abstract unavailable
    
    hrp0095s4.3
- Pathophysiology of hypopituitarism and its clinical implications
- - Abstract unavailable
    
    hrp0095s5.1
  - Abstract unavailable
    
    hrp0095s5.2
  - Abstract unavailable
    
    hrp0095s5.3
- Clinical management of calcium and phosphate disorders
- - The effects of vitamin D supplementation on infant bone mass and body composition
    
    hrp0095s6.1
  - Abstract unavailable
    
    hrp0095s6.2
  - Abstract unavailable
    
    hrp0095s6.3
- Insight into Metabolic disorders and new therapeutic targets
- - Abstract unavailable
    
    hrp0095s7.1
  - The circadian clock in insulin resistance and diabetes
    
    hrp0095s7.2
  - Polycystic Ovary Syndrome in Adolescent Girls:Towards a Treatment Focusing on Ectopic Fat
    
    hrp0095s7.3
- Emerging problems in thyroid diseases
- - Abstract unavailable
    
    hrp0095s8.1
  - Diagnosis and Management of Central Congenital Hypothyroidism
    
    hrp0095s8.2
  - Abstract unavailable
    
    hrp0095s8.3
- Individualised monitoring and treatment of type 1 diabetes
- - Abstract unavailable
    
    hrp0095s9.1
  - Abstract unavailable
    
    hrp0095s9.2
  - Abstract unavailable
    
    hrp0095s9.3
- Microbiome and Metabolic Disorders
- - Abstract unavailable
    
    hrp0095s10.1
  - Type 1 Diabetes and The Microbiome
    
    hrp0095s10.2
  - Abstract unavailable
    
    hrp0095s10.3
- Fertility preservation in girls with ovarian insufficiency
- - Abstract unavailable
    
    hrp0095s11.1
  - Abstract unavailable
    
    hrp0095s11.2
  - Abstract unavailable
    
    hrp0095s11.3
- Bone fragility – from mechanisms to clinical management
- - Abstract unavailable
    
    hrp0095s12.1
  - Abstract unavailable
    
    hrp0095s12.2
  - Abstract unavailable
    
    hrp0095s12.3
Meet the Expert
- Pediatric Cushing Disease
- - Pediatric Cushing disease
    
    hrp0095mte1
- Use Androgens During Infancy, Childhood, and Adolescence
- - Diagnosis and management of a child with pituitary adenoma
    
    hrp0095mte2
- The key role of physical activity against the cardiometabolic risk in childhood obesity
- - The key role of physical activity against the cardiometabolic risk in childhood obesity
    
    hrp0095mte3
- Challenges in the care of transgender and gender-diverse youth
- - Abstract unavailable
    
    hrp0095mte4
- Initial evaluation of a suspected difference or disorder of sex development
- - Initial evaluation of a suspected difference or disorder of sex development
    
    hrp0095mte5
- Management of NAFLD and treatment of NASH
- - Abstract unavailable
    
    hrp0095mte6
- Diagnostics and management of hyperandrogenism during childhood and adolescence
- - Diagnostics and Management of Hyperandrogenism During Childhood and Adolescence
    
    hrp0095mte7
- Endocrine consequences and management of anorexia nervosa
- - Abstract unavailable
    
    hrp0095mte8
How Do I…
- How Do I… Session 1
- - How Do I Diagnose and manage primary adrenal insufficiency
    
    hrp0095hdi1.1
  - How do I manage severe obesity
    
    hrp0095hdi1.2
  - Abstract unavailable
    
    hrp0095hdi1.3
- How Do I… Session 2
- - How do I …Manage communication with families after onset of T1D?
    
    hrp0095hdi2.1
  - How do I replace oestrogens in Turner syndrome?
    
    hrp0095hdi2.2
  - Abstract unavailable
    
    hrp0095hdi2.3
Controversies
- Neonatal Hyper thyrotropinemia: To treat or not to treat?
- - Abstract unavailable
    
    hrp0095con1.1
  - Abstract unavailable
    
    hrp0095con1.2
Novel Advances
- Novel Advances Session
- - Abstract unavailable
    
    hrp0095na1.1
  - Abstract unavailable
    
    hrp0095na1.2
GPED
- GPED Symposium
- - Abstract unavailable
    
    hrp0095gped1.1
  - Abstract unavailable
    
    hrp0095gped1.2
Young Investigators
- Section
- - Abstract unavailable
    
    hrp0095yi1.1
  - Abstract unavailable
    
    hrp0095yi1.2
  - Abstract unavailable
    
    hrp0095yi1.3
Working Group Symposia
- ESPE Working Group on Disorders of Sex Development (DSD) Symposium
- - Fertility Preservation in Experimental Models in DSD
    
    hrp0095wg1.1
  - Abstract unavailable
    
    hrp0095wg1.2
  - Abstract unavailable
    
    hrp0095wg1.3
- ESPE Working Group on Obesity Symposium
- - Abstract unavailable
    
    hrp0095wg2.1
  - Abstract unavailable
    
    hrp0095wg2.2
  - Abstract unavailable
    
    hrp0095wg2.3
  - Abstract unavailable
    
    hrp0095wg2.4
  - Abstract unavailable
    
    hrp0095wg2.5
- ESPE Working Group on Bone and Growth Plate (BGP) Symposium
- - Abstract unavailable
    
    hrp0095wg3.1
  - Abstract unavailable
    
    hrp0095wg3.2
  - Abstract unavailable
    
    hrp0095wg3.3
- ESPE Working Group on Diabetes Technology (DT) Symposium
- - Use of Automated Insulin Delivery systems (AIDs) in preschool children
    
    hrp0095wg4.1
  - Abstract unavailable
    
    hrp0095wg4.2
  - Abstract unavailable
    
    hrp0095wg4.3
  - Abstract unavailable
    
    hrp0095wg4.4
- ESPE Working Group on Paediatric and Adolescent Gynaecology (PAG) Symposium
- - Epigenetics of delayed puberty: recent advances
    
    hrp0095wg5.1
  - Pubertal induction of female delayed puberty: when and how
    
    hrp0095wg5.2
  - Differential diagnosis of pubertal delay in girls - What’s new?
    
    hrp0095wg5.3
  - Abstract unavailable
    
    hrp0095wg5.4
- ESPE Working Group on Gender Incongruence (GI) Symposium
- - Abstract unavailable
    
    hrp0095wg6.1
  - Abstract unavailable
    
    hrp0095wg6.2
  - Abstract unavailable
    
    hrp0095wg6.3
- ESPE Working Group on Turner Syndrome Symposium
- - Abstract unavailable
    
    hrp0095wg7.1
  - Abstract unavailable
    
    hrp0095wg7.2
  - Abstract unavailable
    
    hrp0095wg7.3
  - Abstract unavailable
    
    hrp0095wg7.4
  - Abstract unavailable
    
    hrp0095wg7.5
  - Abstract unavailable
    
    hrp0095wg7.6
- ESPE Nursing and Allied Health Working Group (PENS) Symposium
- - Benefits of multidisciplinary care in Prader-Willi syndrome
    
    hrp0095wg8.1
  - Abstract unavailable
    
    hrp0095wg8.2
Endo-ERN Symposium
- Section
- - Endo-ERN – paving the way to life-long expert care for rare endocrine conditions
    
    hrp0095ee1.1
  - Abstract unavailable
    
    hrp0095ee1.2
  - Abstract unavailable
    
    hrp0095ee1.3
  - Abstract unavailable
    
    hrp0095ee1.4
ESPE Yearbook Sessions
- Year of Paediatric Endocrinology 1
- - Abstract unavailable
    
    hrp0095yb1.1
  - Abstract unavailable
    
    hrp0095yb1.2
  - Abstract unavailable
    
    hrp0095yb1.3
  - Abstract unavailable
    
    hrp0095yb1.4
  - Abstract unavailable
    
    hrp0095yb1.5
- Year of Paediatric Endocrinology 2
- - Abstract unavailable
    
    hrp0095yb2.1
  - Abstract unavailable
    
    hrp0095yb1.2
  - Abstract unavailable
    
    hrp0095yb2.3
  - Abstract unavailable
    
    hrp0095yb2.4
  - Abstract unavailable
    
    hrp0095yb2.5
- Year of Paediatric Endocrinology 3
- - Abstract unavailable
    
    hrp0095yb3.1
  - Abstract unavailable
    
    hrp0095yb3.2
  - Abstract unavailable
    
    hrp0095yb3.3
  - Abstract unavailable
    
    hrp0095yb3.4
  - Abstract unavailable
    
    hrp0095yb3.5
Henning Andersen Award Winners
- Development of Anorexigenic and Glucoregulatory Chimeric Peptides
- - Development of Anorexigenic and Glucoregulatory Chimeric Peptides
    
    hrp0095ha1
- The genetic landscape of children born small for gestational age with persistent short stature
- - The genetic landscape of children born small for gestational age with persistent short stature
    
    hrp0095ha2
Free Communications
- Thyroid
- - Neonatal TSH screening for congenital hypothyroidism: before discharge or at home?
    
    hrp0095fc1.1
  - Comorbidity in congenital hypothyroidism - A nationwide population-based cohort study
    
    hrp0095fc1.2
  - Meta-analysis of DNA methylation datasets identifies aberrant DNA methylation of thyroid function and development genes in Down syndrome
    
    hrp0095fc1.3
  - Children at cardio-metabolic risk raise their circulating concentrations of TSH and free T3
    
    hrp0095fc1.4
  - Subclinical Hypothyroidism and Incident Depression in Adolescents and Young Adults: Results from a Nationwide Representative Prospective Study
    
    hrp0095fc1.5
  - Thyroid complications after haemopoietic stem cell transplantation in children and adolescents
    
    hrp0095fc1.6
- Bone, Growth Plate and Mineral Metabolism
- - Derivation of local reference intervals for serum phosphate to improve diagnosis of Hypophosphataemic rickets
    
    hrp0095fc2.1
  - Final heights in 398 patients with X-linked hypophosphatemia (XLH) over the last decades in France, a surrogate marker of improved disease management. Study of a large cohort of XLH patients born between 1950 and 2006
    
    hrp0095fc2.2
  - First interim analysis of the International X-Linked Hypophosphataemia (XLH) Registry: Baseline characteristics of children treated with conventional therapy and burosumab
    
    hrp0095fc2.3
  - Patient-reported outcomes from a randomized open-label phase 3 trial comparing burosumab vs conventional therapy in children with X-linked hypophosphatemia: results from the 24-week treatment extension period
    
    hrp0095fc2.4
  - Effects of burosumab treatment on mineral homeostasis in children and adolescents with X-linked hypophosphatemia: lessons from the German XLH Registry
    
    hrp0095fc2.5
  - Pseudohypoparathyroidism Type 1A (PHP1A): Growth patterns under growth hormone therapy for short stature
    
    hrp0095fc2.6
- Early Life and Multisystem Endocrinology
- - HYPO-CHEAT: Personalised Technology Reduces Real-World Hypoglycaemia by 25%
    
    hrp0095fc3.1
  - Results from a Global, Multi-Center, Phase 2b Study (RIZE) in Congenital Hyperinsulinism: Characterization of a High Unmet Treatment Need and Glycemic Response to RZ358
    
    hrp0095fc3.2
  - Targeting androgen production by post-translational regulation of CYP17A1 lyase activity
    
    hrp0095fc3.3
  - A common polymorphism in the human P450 reductase gene (POR) causes defective steroid and drug metabolism due to protein instability
    
    hrp0095fc3.4
  - Evaluating the Utility of Bi-functional Degrader Molecules for Selective Inhibition of PDE4 In Acrodysostosis Type2
    
    hrp0095fc3.5
  - The European Registries for Rare Endocrine Conditions (EuRRECa): the Use of a Core Registry for Collecting Common Data Elements and Clinician and Patient Reported Outcomes
    
    hrp0095fc3.6
- Fat, Metabolism and Obesity
- - Natural History of LEP, LEPR and MC4R Deficiencies – A Population-Based Study
    
    hrp0095fc4.1
  - Positive effects of a structured pre- and post-bariatric surgery program on follow-up rate and supplement intake in adolescents and youths- Results from the German YES cohort
    
    hrp0095fc4.2
  - Impaired Brain Satiety Responses by Functional Neuroimaging After Weight Loss Therapy in Children with Obesity
    
    hrp0095fc4.3
  - Inhibition of Neuritin 1 induces browning in human white adipocytes and protects from obesity in vivo
    
    hrp0095fc4.4
  - Pten knockout in osteoprogenitor cells leads to loss of adipose tissue
    
    hrp0095fc4.5
  - Influence of growth hormone status and glucose metabolism on hs-Troponin T and NT-proBNP levels in a cohort of healthy children (The LIFE child study)
    
    hrp0095fc4.6
- Adrenals and HPA Axis
- - Transcriptome profiling of adrenocortical tumors from children with unfavorable disease presentation
    
    hrp0095fc5.1
  - Thioredoxin Reductase 2 (TXNRD2) Variant As A Cause Of Micropenis, Undescended Testis And Selective Glucocorticoid Deficiency
    
    hrp0095fc5.2
  - The liver as a site for rAAV-induced ectopic adrenocortical enzyme expression
    
    hrp0095fc5.3
  - Reference Growth Charts in Children with Congenital Adrenal Hyperplasia
    
    hrp0095fc5.4
  - Influence of prenatal environment and genetic background on glucocorticoid steroid metabolism in monozygotic twins with intra-twin birthweight-differences
    
    hrp0095fc5.5
  - ACTH Stimulation Decreases Ischemia-Modified Albumin Levels In Vivo
    
    hrp0095fc5.6
- Sex Development and Gonads
- - AMH levels in infancy and mid-childhood predict ovarian activity in adolescence: a longitudinal study of healthy girls
    
    hrp0095fc6.1
  - Predictive value of ovarian reserve parameters for follicle detection in ovarian tissue cryopreservation
    
    hrp0095fc6.2
  - Gonadal morphology in 46,XY gonadal dysgenesis: I-DSD Registry-based study
    
    hrp0095fc6.3
  - FATE-1 expression during human fetal testis development, in prepubertal boys and in infertile men
    
    hrp0095fc6.4
  - Phenotypes in a large international cohort of individuals with SF-1/NR5A1 variants
    
    hrp0095fc6.5
  - Breast ultrasonography: How useful in the diagnosis of precocious puberty?
    
    hrp0095fc6.6
- Growth and Syndromes
- - How to detect children with monogenic etiology of familial short stature?
    
    hrp0095fc7.1
  - Post-hoc subgroup analysis of the pivotal phase 3 study of once-weekly somatrogon vs once-daily Genotropin: results from subjects with peak stimulated growth hormone value <6.7 ng/ml
    
    hrp0095fc7.2
  - Italian long-term data on efficacy and safety of rhGH therapy in children with SHOX deficiency: the final report of a national survey performed into ISPED Growth Study Group
    
    hrp0095fc7.3
  - Novel puberty aligned references for height, weight and BMI -making personalized medicine in paediatric endocrinology possible
    
    hrp0095fc7.4
  - Population-based assessment of cardiometabolic-related diagnoses in youth with Turner Syndrome: A PEDSnet Study
    
    hrp0095fc7.5
  - The Multifaceted Burden Experienced by Caregivers of Individuals With Bardet-Biedl Syndrome: Findings from the CARE-BBS Study
    
    hrp0095fc7.6
- Diabetes and Insulin
- - Clinical effectiveness of Liraglutide 3.0 mg for weight management as an adjuvant therapy in obese adolescents with type 1 diabetes: A single-center pilot study
    
    hrp0095fc8.1
  - Detection of anti-islet antibodies in capillary blood by the antibody detection by agglutination-PCR (ADAP) technology is sensitive and suitable for general population screening programs
    
    hrp0095fc8.2
  - Increased zinc alpha2-glycoprotein in patients with type 1 diabetes
    
    hrp0095fc8.3
  - Unravelling environmental and genetic determinants of glycaemic control in children and young adults with Type 1 Diabetes
    
    hrp0095fc8.4
  - Pancreas Unfolded Protein Response is activated in Intrauterine Growth Restriction
    
    hrp0095fc8.5
  - Radio-guided surgery using 68Ga-labelled Exendin in patient with congenital hyperinsulinism
    
    hrp0095fc8.6
- Pituitary, Neuroendocrinology and Puberty
- - COVID-19 and increased prevalence of female precocious puberty in Germany
    
    hrp0095fc9.1
  - Can pre-treatment BMI influence long-term anthropometric and metabolic outcomes in girls with idiopathic central precocious puberty treated with GnRHa?
    
    hrp0095fc9.2
  - Therapeutic outcomes in gonadotropin-replaced males with congenital hypogonadotropic hypogonadism (CHH) with identified genetic variants
    
    hrp0095fc9.3
  - Delayed puberty: unraveling the different trajectories and contributions of AI
    
    hrp0095fc9.4
  - Gonadal Function, Pubertal Development, and Fertility Outcomes in Male and Female Survivors of Medulloblastoma - a Single Tertiary Centre Experience
    
    hrp0095fc9.5
  - Cerebral infarction in childhood-onset craniopharyngioma patients: results of KRANIOPHARYNGEOM 2007
    
    hrp0095fc9.6
- GH and IGFs
- - Growth hormone and childhood-onset craniopharyngioma: When to initiate growth hormone replacement therapy?
    
    hrp0095fc10.1
  - The first-year growth response to once-weekly growth hormone (GH) treatment can be predicted from the pre-treatment blood transcriptome in children with GH deficiency (GHD)
    
    hrp0095fc10.2
  - Near final height in 62 twin pairs with twin-to-twin transfusion syndrome is not associated with the GHRd3 genotype
    
    hrp0095fc10.3
  - Cerebral white matter hyperintensities in young adults born small for gestational age treated with growth hormone during childhood in comparison with untreated controls
    
    hrp0095fc10.4
  - Adjuvant Rituximab - exploratory trial in young people with Graves’ disease
    
    hrp0095fc10.5
  - Defects in QSOX2, a novel regulator of STAT5B nuclear import and transcriptional activity, lead to severe post-natal growth restriction
    
    hrp0095fc10.6
- Late Breaking
- - Deep subcutaneous adipose tissue is associated with hyperinsulinemia in adolescents
    
    hrp0095fc11.1
  - The influence of Non-Alcoholic Fatty Liver Disease and of its genetics on thyroid function in children with obesity
    
    hrp0095fc11.2
  - Dasiglucagon Significantly Reduces Requirement for Intravenous Glucose in Children with Congenital Hyperinsulinism ages 7 Days to 12 Months
    
    hrp0095fc11.3
  - Cerebral white matter hyperintensities in young adults born small for gestational age treated with growth hormone during childhood in comparison with untreated controls
    
    hrp0095fc11.4
  - Adjuvant Rituximab - exploratory trial in young people with Graves’ disease
    
    hrp0095fc11.5
  - The follicle-stimulating hormone receptor is expressed in human pancreatic islet beta-cells and its activation increases glucose stimulated insulin secretion
    
    hrp0095fc11.6
Rapid Free Communications
- Thyroid
- - European Thyroid Association Guideline on the Management of Pediatric Thyroid Nodules and Thyroid Carcinoma
    
    hrp0095rfc1.1
  - Secondary thyroid carcinoma in survivors of childhood cancer: a need to revise current screening recommendations
    
    hrp0095rfc1.2
  - The importance of extra-endocrine features at infancy in multiple endocrine neoplasia type 2B for early diagnosis
    
    hrp0095rfc1.3
  - Usefulness of thyroid function assessment in infants born to mothers with thyroid dysfunction in pregnancy
    
    hrp0095rfc1.4
  - “Screening for congenital hypothyroidism in preterm newborns: Thyroid Stimulating Hormone (TSH) percentiles for weight and gestational age and congenital hypothyroidism features”
    
    hrp0095rfc1.5
  - Frequency and risk factors of hypothyroidism following cardiac catheter in infants with congenital heart diseases: A prospective study
    
    hrp0095rfc1.6
- Bone, Growth Plate and Mineral Metabolism
- - Derivation of local reference intervals for serum phosphate to improve diagnosis of Hypophosphataemic rickets
    
    hrp0095rfc2.1
  - Single-center analysis of quality of life in patients with X-linked hypophosphatemia (XLH)
    
    hrp0095rfc2.2
  - The European Registries for Rare Bone and Mineral Conditions: Registering New Cases of Paediatric Rare Bone and Mineral Conditions Using an Electronic Reporting Tool
    
    hrp0095rfc2.3
  - Dysosteosclerosis is also caused by null mutations of TNFRSF11A
    
    hrp0095rfc2.4
  - Bone biopsy histomorphometric features of vertebral changes in sickle cell disease
    
    hrp0095rfc2.5
  - Genetic liability and late adverse musculoskeletal, metabolic and mental health effects in a cohort of survivors of childhood acute lymphoblastic leukemia – a PETALE study
    
    hrp0095rfc2.6
- Early Life and Multisystem Endocrinology
- - Brain Magnetic Resonance Imaging Changes in Childhood and its possible correlation with Unrecognised Early Life Hypoglycaemia
    
    hrp0095rfc3.1
  - The Hypoglycaemia Error Grid: a UK-wide Consensus on CGM Accuracy Assessment in Hypoglycaemia due to Congenital Hyperinsulinism
    
    hrp0095rfc3.2
  - Analysis of A Series of Italian Apeced Patients with Autoimmune Liver Disease and Enteropathies
    
    hrp0095rfc3.3
  - Immunophenotype and proinflammatory cytokines in ROHHAD(NET) patients compared to age- and sex-matched obese patients
    
    hrp0095rfc3.4
  - Chronotropic Insufficiency impairs Cardiorespiratory Fitness in Boys and Adolescents with Klinefelter Syndrome
    
    hrp0095rfc3.5
  - Continuous growth reference from 24th week of gestation to 24 months by sex for length, weight, and head circumferences, based on the healthiest of Swedish Birth Registry 1990-99 and the GrowUp 1990 Gothenburg cohort
    
    hrp0095rfc3.6
- Fat, Metabolism and Obesity
- - Molecular profiling between obese and non-obese PWS patients
    
    hrp0095rfc4.1
  - Effect of Setmelanotide Treatment in Children and Adolescents With Proopiomelanocortin (POMC) Deficiency, Leptin Receptor (LEPR) Deficiency, and Bardet-Biedl Syndrome (BBS)
    
    hrp0095rfc4.2
  - Phospholipid scramblase 4 regulates adipocyte differentiation via PIP3-mediated AKT activation
    
    hrp0095rfc4.3
  - New insights of monogenic hypercholesterolemia in pediatric patients: basing on a Chinese cohort
    
    hrp0095rfc4.4
  - Cerebral perfusion following childhood-onset craniopharyngioma and the relationship with metabolic rate
    
    hrp0095rfc4.5
  - European Consortium of Lipodystrophies Registry, 2022
    
    hrp0095rfc4.6
- Adrenals and HPA Axis
- - Single centre use of Hydrocortisone granules (Alkindi) in children with Adrenal Insufficiency: the patient experience
    
    hrp0095rfc5.1
  - Case Series: Anastrozole Monotherapy for Non-Classic Congenital Adrenal Hyperplasia
    
    hrp0095rfc5.2
  - Towards understanding the metabolic phenotype of glucocorticoid deficiency in 21-hydroxylase deficiency
    
    hrp0095rfc5.3
  - Increased resting-state functional connectivity in the medial orbitofrontal cortex of patients with autoimmune Addison's disease
    
    hrp0095rfc5.4
  - Mosaic PRKACA duplication causing a novel and distinct phenotype of early-onset Cushing syndrome and acral cutaneous mucinosis
    
    hrp0095rfc5.5
  - The unique methylation pattern of a rare Bilateral para-overian Adrenal Rest Tumor in a girl with severe virilization and Nicotinamide Nucleotide Transhydrogenase mutation
    
    hrp0095rfc5.6
- Sex Development and Gonads
- - Sex-specific ranges and ratios for anogenital distance among Thai full-term newborns
    
    hrp0095rfc6.1
  - Dynamic changes of reproductive hormones in male minipuberty: Temporal dissociation of Leydig- and Sertoli-cell activity
    
    hrp0095rfc6.2
  - Reference intervals of serum estradiol during childhood: comparing and reviewing five studies, effects of gender and age
    
    hrp0095rfc6.3
  - Sertoli cell dysfunction at diagnosis in children with haematological malignancies
    
    hrp0095rfc6.4
  - The effect of GnRHa and testosterone treatment on growth in trans boys
    
    hrp0095rfc6.5
  - Differently Normal: Making sense of Adolescent Perspectives of Early Childhood Experiences associated with Congenital Adrenal Hyperplasia (CAH)
    
    hrp0095rfc6.6
- Growth and Syndromes
- - The grandma X-rays-independent height prediction
    
    hrp0095rfc7.1
  - Once-Weekly Somapacitan vs Daily GH in Children with GH Deficiency: The Randomized Phase 3 REAL 4 Trial
    
    hrp0095rfc7.2
  - Genetic analysis of children with clinically non-syndromic tall stature
    
    hrp0095rfc7.3
  - Efficacy and safety of bilateral epiphysiodesis in extremely tall adolescents
    
    hrp0095rfc7.4
  - A relevant cellular model to study imprinting disorders: dental pulp stem cells
    
    hrp0095rfc7.5
  - Hormone Replacement Therapy After Pubertal Induction in Adolescents and Young Adults with Turner Syndrome: A Survey Study
    
    hrp0095rfc7.6
- Diabetes and Insulin
- - Clinical Spectrum of HNF4A-mody (Mody1): From Neonatal Hyperinsulinism to Diabetes in Adults
    
    hrp0095rfc8.1
  - The impact of age, body mass index, and pubertal stage on C-peptide at type 1 diabetes diagnosis
    
    hrp0095rfc8.2
  - Peripheral nerve conduction velocity in children and young adults with type 1 diabetes mellitus as a marker of metabolic control
    
    hrp0095rfc8.3
  - Developing a regional Southeast Asia diabetes healthcare professional network and webinars programme initiative during the pandemic
    
    hrp0095rfc8.4
  - Impact of type 1 diabetes on the epicardial fat thickness in children and adolescents
    
    hrp0095rfc8.5
  - Short-term effects of elexacaftor/tezacaftor/ivacaftor modulator therapy on glucose tolerance in young people with cystic fibrosis
    
    hrp0095rfc8.6
- Pituitary, Neuroendocrinology and Puberty
- - The Incidence of Congenital Combined Pituitary Hormone Deficiency in Denmark - a national observational study
    
    hrp0095rfc9.1
  - Investigation of Genes Associated with Multiple Pituitary Hormone Deficiencies via Next Generation Sequencing Technology
    
    hrp0095rfc9.2
  - Peak Serum Luteinizing Hormone Levels during Gonadotropin-Releasing Hormone Analog Test among Lean, Overweight and Obese Girls with Central Precocious Puberty
    
    hrp0095rfc9.3
  - Association of Birth Size, Dehydroepiandrosterone Sulfate and Cardiometabolic Risk Factors in Idiopathic Central Precocious Puberty Girls
    
    hrp0095rfc9.4
  - Pubertal milestones in Prader-Willi syndrome: Is there a role of genetic subtypes and MKRN3 status?
    
    hrp0095rfc9.5
  - Craniopharyngiomas diagnosed as incidentalomas - Results of KRANIOPHARYNGEOM 2007
    
    hrp0095rfc9.6
- GH and IGFs
- - Clinical and biochemical predictors of Permanent Growth Hormone Deficiency (PGHD) at retesting
    
    hrp0095rfc10.1
  - Severe primary IGF1 deficiency diagnosed by a standardized IGF1/ IGFBP3 generation test : the Belgian experience
    
    hrp0095rfc10.2
  - A rare HESX1 variant in a patient with congenital hypopituitarism
    
    hrp0095rfc10.3
  - Recombinant PAPP-A2 induces sex-specific increases in body weight and length and changes in bone microstructure in adolescent mice with longitudinal growth reduction induced by Pappa2 deletion
    
    hrp0095rfc10.4
  - Evaluation of health-related quality of life & problem behavior in adults born small for gestational age treated with growth hormone during childhood in comparison with untreated controls
    
    hrp0095rfc10.5
  - Growth Hormone Deficiency in Adult Survivors of Childhood Brain Tumors Treated with Irradiation
    
    hrp0095rfc10.6
- Late Breaking
- - Six-months of treatment with exenatide improves glycemic control, but does not affect endogenous intact GLP-1 concentrations in adolescents with obesity
    
    hrp0095rfc11.1
  - Dynamics of meal-related plasma asprosin levels
    
    hrp0095rfc11.2
  - Predictors of kidney damage development in children with metabolically healthy and metabolically unhealthy obese phenotypes
    
    hrp0095rfc11.3
  - Are GnRH agonists beneficial in final adult height after 8 years old? Data from a Portuguese National Digital Platform of idiopathic Central Precocious Puberty
    
    hrp0095rfc11.4
  - Adjuvant Rituximab - exploratory trial in young people with Graves’ disease
    
    hrp0095rfc11.5
  - Genotype, phenotype characteristics and long-term follow-up of patients with Vitamin D Dependent Rickets Type IA (VDDR1a): A nationwide multicentre retrospective cross-sectional study
    
    hrp0095rfc11.6
Top 20 Posters
- Section
Poster Category 1
- Adrenals and HPA Axis
- - Collection of salivary steroids in children under conditions replicating home sampling
    
    hrp0095p1-1
  - Growth evaluation by applying the QEPS growth model in patients with CAH
    
    hrp0095p1-2
  - Blood pressure (BP) status in Congenital Adrenal Hyperplasia (CAH) – longitudinal analysis of real world data from the I-CAH registry
    
    hrp0095p1-3
  - Glucocorticoid-induced adrenal insufficiency: morning plasma cortisol values safely assess recovery of the HPA axis in pediatrics
    
    hrp0095p1-4
  - Urinary steroid metabolite ratios: sex- and age-dependent changes and use for the differential diagnosis of inborn steroidogenesis disorders
    
    hrp0095p1-5
  - Clinical and Genetic characterization of primary adrenal insufficiency in Sudanese children
    
    hrp0095p1-6
  - Management of mineralocorticoid deficiency in Congenital Adrenal Hyperplasia – a single centre study
    
    hrp0095p1-7
  - Evolution of the Short Synacthen Test over a decade - a single UK centre’s experience
    
    hrp0095p1-8
  - Identification of a novel CYP11B2 variant in a family with varying degrees of aldosterone synthase deficiency
    
    hrp0095p1-9
  - Comparison of assays for salivary cortisol and cortisone in the diagnosis of Cushing's syndrome
    
    hrp0095p1-10
  - Low-dose ACTH Stimulation Test: Comparison of Cortisol Response at 30, 40, and 60 Minutes
    
    hrp0095p1-11
  - Novel Homozygous Mutation in a Boy with Pseudohypoaldosteronism Type 1
    
    hrp0095p1-12
  - Clinical characteristics and pubertal development in Greek girls with premature adrenarche
    
    hrp0095p1-13
  - Demographic, Clinical, Hormonal And Genetic Characteristics Of Children And Adolescents With Congenital Adrenal Hyperplasia Due To 11-Beta Hydroxylase Deficiency
    
    hrp0095p1-14
  - Growth from Birth to Adult Height in Patients with Classical Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency: A Collaborative Study
    
    hrp0095p1-15
  - Long-term follow-up of three male siblings with a novel NNT pathogenic variant causing primary adrenal insufficiency
    
    hrp0095p1-16
  - Expanding the phenotype of deglycosylation disorders: Adrenal Insufficiency and Micropenis in NGLY1-CDDG
    
    hrp0095p1-17
  - Very early and atypical presentation of Triple A (Allgrove) syndrome
    
    hrp0095p1-18
  - Gene Chimeras Involving CYP21A2 and TNXB Genes in Spanish Patients with Congenital Adrenal Hyperplasia (CAH)
    
    hrp0095p1-201
  - Abstract unavailable
    
    hrp0095p1-202
  - P450 oxireductase (POR) regulates blood brain (BBB) maturation by mediating retinoic acid (RA) metabolism in a model of the human BBB
    
    hrp0095p1-203
  - Reduced cognitive function in children with classical 21-hydroxylase deficient congenital adrenal hyperplasia (21OHD-CAH)
    
    hrp0095p1-204
  - Exploring the growth curves of 248 Chinese patients aged 0-3 years with salt-wasting 21-hydroxylase deficiency
    
    hrp0095p1-205
  - Primary adrenal insufficiency in a patient with biallelic QRSL1 mutations
    
    hrp0095p1-206
  - Clinical and genetic characteristics of androgen insensitivity syndrome
    
    hrp0095p1-207
  - Targeting melanocortin type 2 receptor (MC2R) with peptides for the treatment of congenital adrenal hyperplasia
    
    hrp0095p1-208
  - Systematic review of cortisol levels during acute illnesses in children and young people not known to have glucocorticoid deficiency
    
    hrp0095p1-209
  - Surgical outcomes and related complications in Graves' disease (GD)
    
    hrp0095p1-210
  - Effect of maternal steroid medication prescribed during pregnancy on neonatal adrenal function
    
    hrp0095p1-211
  - Molecular Analyses of A Virilized Newborn. Implications in Clinical Management
    
    hrp0095p1-212
  - Alterations in glucocorticoid metabolism as a possible cause of hypertension in childhood obesity
    
    hrp0095p1-213
  - Development and validation of simultaneous quantification of urinary catecholamines and free metanephrines by UHPLC-MS/MS method
    
    hrp0095p1-214
  - Salt-Wasting CAH phenotype as a result of the TNXA/TNXB Chimera 1 (CAH-X CH-1) and the severe IVS2-13A/C>G in CYP21A2 gene
    
    hrp0095p1-215
  - Salivary Cortisol in Children with Congenital Adrenal Hyperplasia and Different Treatment Regimens
    
    hrp0095p1-216
  - Precocious Pubarche in Girls - A Clinical Sign for Underlying Hyperandrogenic Disease
    
    hrp0095p1-217
  - Increased Basal Levels of 17-Hydroxyprogesterone In The Covid ERA: Must We Change The Cut-Off Point To Request Acth Test?
    
    hrp0095p1-401
  - Glucose regulation and cardiovascular health in children and young people with primary adrenal insufficiency
    
    hrp0095p1-402
  - Outcomes of treatment in pediatric Cushing`s disease
    
    hrp0095p1-403
  - Change in androgens and adrenal hormones during long-term osilodrostat treatment in patients with Cushing's disease: Results from the Phase III, prospective LINC 3 study
    
    hrp0095p1-404
  - Impact of urinary and late-night salivary cortisol levels on clinical signs of hypercortisolism and quality of life in patients with Cushing's disease treated with osilodrostat
    
    hrp0095p1-405
  - Salt-wasting in newborns due to adrenal dysfunctions other than 21 OH Congenital adrenal hyperplasia (CAH) : a single center experience
    
    hrp0095p1-406
  - Agreement between Acth-low test and Insuline Tolerance Test in Patients with Risk Factors for Central Adrenal Insufficiency
    
    hrp0095p1-407
  - Diverse clinical features, genetic etiologies, and histopathological features of adrenal neoplasms in children and adolescents
    
    hrp0095p1-408
  - Clinical, laboratory and body composition profile of young female patients with non-classic congenital adrenal hyperplasia
    
    hrp0095p1-409
  - Neonatal Screening for Congenital Adrenal Hyperplasia in Saudi Arabia: A Retrospective, Descriptive study
    
    hrp0095p1-410
  - Prevalence and Incidence of Congenital Adrenal Hyperplasia in Denmark – a nationwide cohort study
    
    hrp0095p1-411
  - A single centre experience of aromatase inhibitors to limit bone age advancement in pre-pubertal boys with adrenal disorders causing androgen excess
    
    hrp0095p1-412
  - Osilodrostat provides sustained clinical benefits and improves health-related quality of life in patients with cushing's disease: results from the Phase III LINC 4 study
    
    hrp0095p1-413
  - Predictive factors of somatostatin receptor ligand response in acromegaly - a prospective study
    
    hrp0095p1-414
  - Basal cortisol measurements in the prediction of low-dose ACTH stimulation test outcomes
    
    hrp0095p1-415
  - Cabergoline monotherapy in acromegaly - a multicenter, retrospective, cohort study of non-irradiated patients using current criteria for disease control
    
    hrp0095p1-416
  - A patient with autoimmune polyglandular syndrome type 1 with atypical presentation
    
    hrp0095p1-417
- Bone, Growth Plate and Mineral Metabolism
- - The endocrine society practice guideline revisited: why do nowadays patients undergo screening for cushing' syndrome, and with which outcome?
    
    hrp0095p1-19
  - Characterization of adrenal miRNA-based dysregulations in Cushing's Syndrome
    
    hrp0095p1-20
  - Time from referral to definitive treatment in Cushing's syndrome
    
    hrp0095p1-21
  - Mesenchymal Stem Cells exposed to persistently high glucocorticoid levels develop insulin-resistance and altered lipolysis: a promising in vitro model to study Cushing's Syndrome
    
    hrp0095p1-22
  - Comparison of adult height prediction models against the average height of the Mexican population
    
    hrp0095p1-23
  - Midnight ACTH vs morning ACTH levels in Cushing's syndrome diagnosis
    
    hrp0095p1-24
  - Efficacy and safety of bisphosphonate treatment in pediatric patients with osteoporosis caused by immobilization
    
    hrp0095p1-25
  - Outcomes of four patients with osteonecrosis after one-year pamidronate treatment
    
    hrp0095p1-26
  - Effects of Pharmacological Inhibition of BCL-2 on Linear Bone Growth
    
    hrp0095p1-27
  - Pain as an onset symptom in hereditary hypophosphatemic rickets with hypercalciuria, a case report
    
    hrp0095p1-28
  - Don’t forget the bones: incidence and risk factors of Metabolic Bone Disease in a cohort of preterm infants
    
    hrp0095p1-29
  - Vitamin D may facilitate Clock/Bmal1-DNA interactions in a Vitamin D receptor-independent fashion
    
    hrp0095p1-30
  - Osteogenesis imperfecta: the effectiveness of bisphosphonates
    
    hrp0095p1-31
  - Six-year clinical outcome of enzyme replacement therapy for patients with perinatal lethal and infantile hypophosphatasia in Korea
    
    hrp0095p1-32
  - Primary or Secondary Bone Fragility? This is The Question
    
    hrp0095p1-33
  - Pubertal Increment in Insulin Resistance is Negatively Associated with Lumbar Bone Mineral Density in 18-Year-Old Males Independently of Body Composition
    
    hrp0095p1-218
  - Use of Zoledronic acid in children with sickle cell disease: a single centre experience
    
    hrp0095p1-219
  - Hypocalcemia as the Initial Presentation of Type2 Bartter Syndrome: A Family Report
    
    hrp0095p1-220
  - Association between early-puberty girls’ bone maturation and linear growth in Shenzhen City：a retrospective study
    
    hrp0095p1-221
  - Infantile Hypercalcemia Type 2 Due to Novel Mutation in SLC34A1 Gene
    
    hrp0095p1-222
  - Real-world data in children with achondroplasia after licensing of Vosoritide
    
    hrp0095p1-223
  - High Vitamin Deficiency Throughout Childhood. Inma-Asturias Cohort. Spain
    
    hrp0095p1-224
  - Nephrolithiasis and hypoparathyroidism with normocalcemia – detecting a new mutation solves the mystery
    
    hrp0095p1-225
  - FGFR3 gene mutation causes hypochondroplasia via autophagy inhibition
    
    hrp0095p1-226
  - Primary Hyperparathyroidism caused by a Mutation of the Vitamin D Receptor Gene
    
    hrp0095p1-227
  - Effect of burosumab treatment on phosphate metabolism and bone health in patients with X-linked hypophosphatemic rickets (XLH). Preliminary data within an Italian sample
    
    hrp0095p1-228
  - Neurological symptoms leading to Pseudohypoparathyreoidism 1B (iPPSD3)
    
    hrp0095p1-229
  - Cleidocranial Dysplasia: a 3 Generations Family with a Novel Mutation, and Growth Hormone treatment
    
    hrp0095p1-230
  - A Case Report of Vitamin D-Dependent Rickets Type 2A Without Alopecia
    
    hrp0095p1-231
  - Beyond Genetics: Three Sisters with Pseudoypoparathyroidism 1A
    
    hrp0095p1-232
  - Serum Bone Markers and Its Associations with Measures of Bone Health in Adolescents with Alpha-thalassemia Requiring Frequent Blood Transfusion
    
    hrp0095p1-418
  - Early-Stage Radiological Markers of Endothelial Dysfunction and Cardiovascular Findings in Patients with Osteogenesis Imperfecta and Their Genotype-Phenotype Correlations: A Case-Control Study
    
    hrp0095p1-419
  - Skeletal phenotype in patients with the monogenic Mulibrey nanism disorder
    
    hrp0095p1-420
  - Novel ACAN Variants in Eight Chinese Families with Short Stature and Literature Review
    
    hrp0095p1-421
  - A heterozygous variant of CYP3A4 in a Chinese boy with Vitamin D-dependent rickets type 3
    
    hrp0095p1-422
  - A case report investigating hereditary hypophosphataemic rickets with hypercalcuria (HHRH), a suspected novel mutation and the FGF23 ‘red herring’
    
    hrp0095p1-423
  - Therapeutic Approach to Primary Hyperparathyroidism: A Case-Report from One Pediatric Endocrinology Center
    
    hrp0095p1-424
  - Association between mothers, breast milk, and infants vitamin D at 2 weeks of age in Japan
    
    hrp0095p1-425
  - Epidemiology of Childhood Fractures in Bulgaria: A Retrospective Survey
    
    hrp0095p1-426
  - The mutation of the FGFR3 gene causes familial acanthosis nigricans with hypochondroplasia syndrome
    
    hrp0095p1-427
  - Extra-articular calcification in an adolescent boy: where history is paramount
    
    hrp0095p1-428
  - Progressive pseudorheumatoid dysplasia as a cause of short stature
    
    hrp0095p1-429
  - Psychological impact of Covid-19 national lockdown on patients with Cushing's syndrome in Italy: a case-control study
    
    hrp0095p1-430
  - Kenny-Caffey Type 2 syndrome (KCT2S) as a rare cause of hypoparathyroidism causing neonatal seizures
    
    hrp0095p1-431
  - Effects of COVID-19 pandemic on serum vitamin D concentration in Korean children
    
    hrp0095p1-432
  - Gene therapy of growth hormone resistant dwarfism in the laron mouse model - comparison of two doses
    
    hrp0095p1-433
- Diabetes and Insulin
- - Early treatment of neonatal diabetes with oral glibenclamide suspension (Amglidia®) in an extremely preterm infant: evidence for efficacy, safety and easiness
    
    hrp0095p1-34
  - Does parental food choice preferences impact on metabolic control of children with type 1 diabetes?
    
    hrp0095p1-35
  - Human umbilical cord derived mesenchymal stem cells alleviate T1DM model via TGFBI-mediated T cells proliferation
    
    hrp0095p1-36
  - The role of insulin resistance and pancreatic β-cell dysfunction in the development of prediabetes in obese adolescents
    
    hrp0095p1-37
  - Severe clinical presentation of congenital hyperinsulinism due to newly discovered mutation of HK1: case report
    
    hrp0095p1-38
  - Case report: Suppression of gonadotropins with contraceptives in type A insulin resistance ameliorates virilizing insulin-induced hyperandrogenism
    
    hrp0095p1-39
  - Pancreatic Shear Wave Elastography in Children with T1D; Relation to Functional B cell mass Pancreatic Reserve
    
    hrp0095p1-40
  - A Rare Cause in Childhood: Mody 11
    
    hrp0095p1-41
  - Symptoms and Glycemic Control in Young People with Type 1 Diabetes following SARS-CoV-2 Infection: an Observational Study
    
    hrp0095p1-42
  - The spectrum of paediatric diabetes subtypes from a single center in a highly consanguineous region
    
    hrp0095p1-43
  - Characterisation of Type 2 Diabetes mellitus in children and young people across 2 large tertiary Paediatric Diabetes centres
    
    hrp0095p1-44
  - Non-insulin-dependent diabetes mellitus due to a variant in MAPK8IP1: a case report
    
    hrp0095p1-45
  - The incidence of Type 1 diabetes mellitus has stopped falling and is rising again in Ireland – a preliminary report from the Irish Childhood Diabetes National Register
    
    hrp0095p1-46
  - Congenital hyperinsulinism: a case with a missense monoallelic heterozygous ABCC8 mutation responsive partially to diazoxide therapy
    
    hrp0095p1-47
  - Maternal Hepatic HKDC1 Expression Impacts Offspring Glucose Metabolism
    
    hrp0095p1-48
  - Impact of Metabolic-associated fatty liver disease (MAFLD) on the Cholesterol efflux capacity of High-density lipoproteins in adolescents with type 2 Diabetes
    
    hrp0095p1-49
  - An Evaluation of MiniMed™ 780G System Performance in Childhood: A Single Center Experience from Turkey
    
    hrp0095p1-50
  - Health-related quality of life and metabolic control in children and young patients with type 1 diabetes and in their parents before and after the COVID-19 lockdown
    
    hrp0095p1-51
  - Relationship between the quantification of physical activity according to the PAQ-c survey and the metabolic control of pediatric patients with type 1 diabetes
    
    hrp0095p1-52
  - One Case Report of MODY5 with MCPH3
    
    hrp0095p1-53
  - Relation between body weight and bone mineral density in type 1 diabetic patients
    
    hrp0095p1-54
  - Screening for disordered eating behaviours and associated factors in children and adolescents with type 1 diabetes
    
    hrp0095p1-55
  - Curative effect contributors of exercise in type one diabetes: Irisin and Sestrin
    
    hrp0095p1-56
  - Diagnosis of gestational diabetes mellitus in the COVID-19 pandemic: comparative analysis of women with positive O'Sullivan test in the same trimester of 2019 and 2020
    
    hrp0095p1-57
  - Developing a digital Southeast Asia Type 1 diabetes healthcare educational platform in local languages during the pandemic
    
    hrp0095p1-58
  - Type 1 diabetes glycated haemoglobin outcomes did not differ by insulin regimen in two large Cambodian tertiary hospitals
    
    hrp0095p1-59
  - Prevalence of Autoimmunity in Relatives of Patients with Type 1 Diabetes: Time to The Clinical Onset of Diabetes and Associated Risk Factors
    
    hrp0095p1-60
  - Increased incidence of childhood type 1 diabetes during COVID-19 pandemic. Figures from an Italian tertiary care center
    
    hrp0095p1-61
  - A rare case of concomitant inflammatory polyneuropathy and type 1 diabetes with Covid 19 in a teenager
    
    hrp0095p1-62
  - Effects of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)-Modulating Therapy on Glucose Metabolism in Cystic Fibrosis Patients
    
    hrp0095p1-233
  - Paediatric Post-Prandial Hyperinsulinaemic Hypoglycaemia
    
    hrp0095p1-234
  - Etiology-based diagnosis of pediatric patients with atypical diabetes using routine and omic-based phenotyping and genotyping: results from the GENEPEDIAB study
    
    hrp0095p1-235
  - A novel homozygous mutation in the Glycerol-3-Phosphate Dehydrogenase 1 gene combined with a heterozygous mutation in the Glucokinase Regulator gene associated with hyperglycaemia, hypertriglyceridaemia and non-alcoholic fatty liver in a 17 year old woman
    
    hrp0095p1-236
  - Neurodevelopmental outcomes in children with congenital hyperinsulinism
    
    hrp0095p1-237
  - Faster-acting insulin Fiasp vs insulin Novorapid in type 1 diabetes children and adolescents with sensor-augmented pump therapy
    
    hrp0095p1-238
  - Why understanding hemoglobin glycated measurement can be important: Santa Juana hemoglobin variant and falsely elevated HbA1c
    
    hrp0095p1-239
  - Successful inpatient use of a fully closed-loop (FCL) insulin delivery system in an adolescent with diabetes secondary to pancreatitis
    
    hrp0095p1-240
  - 3 Screen ICA TM Elisa - A New Tool for Identify Pre-Clinical Diabetes in First-Degree Relatives of Patients with Type 1 Diabetes (Pre-D1Abetes Study)
    
    hrp0095p1-241
  - The lncOb rs10487505 polymorphism impairs insulin sensitivity and glucose tolerance in children and adolescents with obesity
    
    hrp0095p1-242
  - Resistant Graves' thyrotoxicosis with adverse cardiovascular effects
    
    hrp0095p1-243
  - Glycemic Outcomes and Safety During the MiniMed™ 780G Advanced Hybrid Closed-Loop System in Egyptian Patients with Type 1 Diabetes
    
    hrp0095p1-244
  - Analysis of peripheral nerve conduction function and its influencing factors in children and adolescents with type 1 diabetes mellitus
    
    hrp0095p1-245
  - Developmental surveillance in children with Congenital Hyperinsulinism (CHI) - Personalising care
    
    hrp0095p1-246
  - Monogenic diabetes clinic: 3-year experience
    
    hrp0095p1-247
  - Carbohydrate counting efficacy in glycaemic control among children and adolescents with type 1 diabetes mellitus: a systematic review and meta-analysis
    
    hrp0095p1-248
  - Glycemic control and complications of type 2 diabetes mellitus in children and adolescents during the COVID-19 outbreak
    
    hrp0095p1-249
  - The Metabolic Syndrome is frequent in Children and Adolescents with Type 1 Diabetes Compared to Healthy Controls
    
    hrp0095p1-250
  - Does the Diagnosis of Type 1 Diabetes Affect Only Diabetics? What About Family?
    
    hrp0095p1-251
  - Novel insights on the associations between specific brain tract segmental alterations, glucose levels, and cognitive performance among adolescents with type 1 diabetes
    
    hrp0095p1-252
  - Central diabetes insipidus from a patients′ perspective - from management to psychological co-morbidities and re-naming of the condition
    
    hrp0095p1-253
  - Auxological parameters and metabolic control in children and young patients with type 1 diabetes 1-year after COVID-19 pandemic
    
    hrp0095p1-254
  - Initial results in the initiation of the hybrid closed-loop system in Spanish children with type 1 diabetes mellitus
    
    hrp0095p1-255
  - Analysis of NGS panel examination in patients suspected of MODY in a single tertiary hospital
    
    hrp0095p1-256
  - A novel mutation in INS gene in an infant with neonatal diabetes mellitus: A case report and functional study
    
    hrp0095p1-257
  - Effect of Multidisciplinary Intervention on Emotional and Behavioral profile in Children with Type 1 Diabetes Mellitus: An Interventional Longitudinal study
    
    hrp0095p1-258
  - Tear Proteomics in Children and Adolescents with Type 1 Diabetes Mellitus and Correlation with Cognitive Function Levels
    
    hrp0095p1-259
  - The association between Epilepsy and Diabetes mellitus diagnosed before 2 years of age
    
    hrp0095p1-260
  - Parental stress in children with type 1 diabetes from different socioeconomic backgrounds
    
    hrp0095p1-261
  - Role of glucose variability on linear growth in children with Type 1 Diabetes
    
    hrp0095p1-434
  - Are we sure that the prevalence of SARS-CoV-2 infection is not underestimated? Usefulness of serological antibodies assays in children and adolescents with type 1 diabetes
    
    hrp0095p1-435
  - Growth hormone-releasing hormone (GHRH) promotes survival and proliferation of neural stem cells and reduces amyloid-[beta]-induced toxicity
    
    hrp0095p1-436
  - The Relationship between Visceral Adipose Index and Metabolic Syndrome in Children with Type 1 Diabetes Mellitus
    
    hrp0095p1-437
  - Abstract unavailable
    
    hrp0095p1-438
  - Deciphering Monogenic Diabetes Mellitus in Spanish Pediatric Patients: A Cross-Sectional Study
    
    hrp0095p1-439
  - Abstract unavailable
    
    hrp0095p1-440
  - NEUROD1 mutation as a cause of neonatal diabetes: the rarest of the rare!
    
    hrp0095p1-441
  - A Continuous Quality Improvement Effort Implemented by The Italian Network of Pediatric Diabetes Clinics
    
    hrp0095p1-442
  - Co-segregation analysis and functional trial in vivo of candidate genes for monogenic diabetes
    
    hrp0095p1-443
  - Influence of Family Status and Living Circumstances on Metabolic Control in Patients with Type 1 Diabetes
    
    hrp0095p1-444
  - Glucagon Response to Hypoglycemia During Extended Oral Glucose Tolerance Test in Children with Cystic Fibrosis and Comparing with Healthy Peers
    
    hrp0095p1-445
  - Case Report: LRBA deficiency related Monogenic Neonatal Diabetes Mellites
    
    hrp0095p1-446
  - Access and use of new technologies in diabetes care in patients that need an Interpreter compared to those that do not
    
    hrp0095p1-447
  - The effect of physical activity on leptin and adiponectin in youth with T1D
    
    hrp0095p1-448
  - Do-It-Yourself Artificial Pancreas Systems in a PediatricPopulation with Type 1 Diabetes in a Real-life Setting: The AWeSoMe Study Group Experience
    
    hrp0095p1-449
  - Unstable glycaemia in rare, early-onset Shwachman-Diamond syndrome-associated diabetes mellitus
    
    hrp0095p1-450
  - Maintaining insulin and medical supplies for disadvantaged people with Type 1 Diabetes in Southeast Asia during the COVID-19 pandemic
    
    hrp0095p1-451
  - Limited genotype-phenotype correlation in FOXP3 gene within same family member
    
    hrp0095p1-452
  - Usability of CGM for hyperglycemia detection during systemic glucoriticoid treatment
    
    hrp0095p1-453
  - Clinical and genetic evaluation of patients with maturity onset diabetes of the young (MODY) : Single center experience
    
    hrp0095p1-454
  - An Adolescent with HNF1B Deletion. A Case Report
    
    hrp0095p1-455
  - Outmoded by Mody? A Case Report of HNF1A-Mody in Paediatric Stroke
    
    hrp0095p1-456
  - Rabson Mendenhall Syndrome: A Rare Insulin Resistance Syndrome
    
    hrp0095p1-457
  - BMI in Bulgarian children and adolescents with type 1 diabetes mellitus – data of two national cross-sectional studies
    
    hrp0095p1-458
  - Staying cool in the heat − the role of thyroid hormone receptor [alpha] in thermoregulation
    
    hrp0095p1-459
  - Thymic hyperplasia associated with Graves' Disease: lessons from the resolution of six individual cases
    
    hrp0095p1-460
  - Risks and Metabolic Consequences of Ramadan Fasting on Egyptian Adolescents With Type 1 Diabetes Mellitus
    
    hrp0095p1-461
- Fat, Metabolism and Obesity
- - Association of transient elastography and ultrasonographic fatty liver indicator in pediatric non-alcoholic steatohepatitis
    
    hrp0095p1-63
  - microRNA-27a - a strand specific regulator of adipogenesis and adipocyte function
    
    hrp0095p1-64
  - Congenital Leptin Receptor deficiency: An Indian family with novel Homozygous LEPR gene mutation (LEPR):c.1752G>A (P.Lys584=) presenting with severe early onset obesity
    
    hrp0095p1-65
  - Effect of gender and age on the mental well-being and self-esteem of adolescents living with obesity: subanalysis from the ACTION Teens global study
    
    hrp0095p1-66
  - Effect of unawareness of obesity on perceptions of obesity and food/diet among adolescents living with obesity and their caregivers: subanalysis from the ACTION Teens global study
    
    hrp0095p1-67
  - Gender variability and associations of blood dopamine, leptin and insulin in overweight children
    
    hrp0095p1-68
  - Clinical Evolution After A 24 Month Nutritional Intervention Based on Carbohydrate Restriction in Adolescents with Obesity
    
    hrp0095p1-69
  - Abstract unavailable
    
    hrp0095p1-70
  - Circulating mRNA and miRNA Signatures as Predictive Markers of Lifestyle Modification Outcomes in Pediatric Obesity Treatment
    
    hrp0095p1-71
  - Energy Drinks: Acute Effects on Central Hemodynamics in Healthy Children and Teenagers. A Randomized Trial
    
    hrp0095p1-72
  - Glucose alterations, insulin resistance, hypertension, and activation of the renin-aldosterone system are strictly associated in pediatric obesity
    
    hrp0095p1-73
  - Metabolic risk assessment in children and adolescents using the tri-ponderal mass index
    
    hrp0095p1-74
  - The association between C-reactive protein, metabolic syndrome, and prediabetes in Korean children and adolescents
    
    hrp0095p1-75
  - Glucagon-like peptide-1 analogues: a new way to quit smoking? SKIP - a randomised controlled study
    
    hrp0095p1-76
  - Abstract unavailable
    
    hrp0095p1-77
  - Obstructive sleep apnea (OSA) is associated with the impairment of beta-cell response to glucose in children and adolescents with obesity
    
    hrp0095p1-78
  - Severe early-onset obesity and diabetic ketoacidosis due to a novel homozygous c.169C>T p.Arg57* mutation in CEP19 gene
    
    hrp0095p1-79
  - Obesity and overweight increased in pre-school Swedish children during the COVID-19 pandemic
    
    hrp0095p1-80
  - Adipocytokines profile in patients with Graves' orbitopathy and the effect of high-dose corticosteroids
    
    hrp0095p1-81
  - Cardiometabolic Health in Adolescents Conceived by Assisted Reproductive Technologies: Preliminary Results from the Munich heARTerY-Study
    
    hrp0095p1-82
  - Association between thyroid hormones and cardiometabolic risk factors in euthyroid overweight and obese children and adolescents following the implementation of a lifestyle intervention program
    
    hrp0095p1-83
  - Osteocalcin in Infancy and Early Childhood Related to Covariates and Growth: A Longitudinal Birth Cohort Study
    
    hrp0095p1-84
  - Ramadan fasting without the doctor's consent: which patient, and what impact? Results of a prospective study
    
    hrp0095p1-85
  - Detailed cardiac phenotyping of obese patients with mutations in the genes POMC and MC4R
    
    hrp0095p1-86
  - Thyroid Disfunctions During Pediatric Obesity: Possible Role in Obese Children with Insulin Resistance
    
    hrp0095p1-87
  - Altered inflammatory parameters and chemokine network in obese children
    
    hrp0095p1-262
  - Small integral membrane protein 10 like 1 (SMIM10L1) affects adipogenesis and apoptosis in adipose progenitor cells
    
    hrp0095p1-263
  - Triglyceride–glucose–alanine aminotransferase index as a novel and superior predictor for non-alcoholic fatty liver disease in children and adolescents
    
    hrp0095p1-264
  - A point mutation of SH2B1: a new cause of monogenic obesity?
    
    hrp0095p1-265
  - WBC count. A potential tool for suspecting Cushing's syndrome (CS)
    
    hrp0095p1-266
  - Feasibility of integrating an mHealth intervention to increase exercise and physical activity adherence into a weight management service for adolescents with severe obesity: MOTIVATE-WMA
    
    hrp0095p1-267
  - Preliminary evidence for a strong effect of leptin on mood and behaviour in patients with congenital leptin deficiency
    
    hrp0095p1-268
  - Characterization of glucose metabolism in obese and overweight children and adolescents during COVID-19 pandemic period
    
    hrp0095p1-269
  - Homology modelling analysis provides insight into ADCY3, a candidate obesity gene
    
    hrp0095p1-270
  - Serum Osteopontin, NGAL and Sclerostin concentrations in children and adolescents with overweight and obesity
    
    hrp0095p1-271
  - Characterization of molecular pathway alterations in Cushing's Syndrome
    
    hrp0095p1-272
  - An adult-based genetic risk score for hepatic fat associates with liver and lipid traits in Danish children
    
    hrp0095p1-273
  - Thyroid function in overweight and obese children and adolescents
    
    hrp0095p1-274
  - Cardio-metabolic health in Danish children aged 7-10 years conceived after assisted reproductive technology
    
    hrp0095p1-275
  - Natural History of Pregnancy and Pregnancy Outcomes in Metreleptin-Treated vs Untreated Subjects with Lipodystrophy
    
    hrp0095p1-276
  - Presenting clinical features of Cushing's syndrome and non-classic hypercortisolism
    
    hrp0095p1-277
  - e-REC Capturing The Occurrence and Burden Of COVID-19 Infections In People With Rare Genetic Obesity Disorders
    
    hrp0095p1-278
  - Sex-specific POMC DNA methylation variability is associated with increased body weight
    
    hrp0095p1-279
  - A rare cause of monogenic obesity: Schaaf-Yang syndrome due to a novel MAGEL2 gene variant
    
    hrp0095p1-280
  - Impact of Covid-19 pandemic on the efficacy of outpatient counseling in childhood obesity management
    
    hrp0095p1-281
  - Significant improvement in dietary behaviors and quality of life among adolescents with obesity in the COVID19 lockdown through telehealth
    
    hrp0095p1-282
  - Single Nucleotide Polymorphisms (SNPs) Profile as Predictive Markers of Lifestyle Modification Outcomes in Pediatric Obesity Treatment
    
    hrp0095p1-283
  - Impact of bariatric surgery on newborn growth parameters
    
    hrp0095p1-284
  - Nutritional disparities among Brazilian children: study of the temporal trend of the BMI from 2010 to 2021
    
    hrp0095p1-285
  - Impact of COVID-19 vaccination on incidence of graves' disease
    
    hrp0095p1-462
  - Clinical characteristics of sitosterolemic children with xanthomas as the first manifestation
    
    hrp0095p1-463
  - Triglyceride glucose index is associated with the severity of ultrasonographic fatty liver indicator in pediatric non-alcoholic steatohepatitis
    
    hrp0095p1-464
  - Use of liraglutide for treatment of childhood obesity: early experiences from a tier 3 paediatric obesity service
    
    hrp0095p1-465
  - Predictive factors of success of radiometabolic therapy in Graves' disease
    
    hrp0095p1-466
  - The Level of Inflammatory Markers and their Relationship with Fat Tissue Distribution in Children with Obesity and Type 2 Diabetes
    
    hrp0095p1-467
  - From hyper to hypothyroidism: pitfalls in graves' disease following DRESS syndrome
    
    hrp0095p1-468
  - Triglyceride-glucose-alanine aminotransferase index is associated with the severity of transient elastography in pediatric non-alcoholic steatohepatitis
    
    hrp0095p1-469
  - High carbohydrate diet results in sex-specific differences in energy homeostasis in mice with PAPP-A2 deficiency
    
    hrp0095p1-470
  - Hyperpigmentation in Graves' disease
    
    hrp0095p1-471
  - Venture: Design of a Phase 3 Multicenter, 1-Year, Open-Label Trial of Setmelanotide in Pediatric Patients Aged 2 to <6 Years With Rare Genetic Diseases of Obesity
    
    hrp0095p1-472
  - Prevalence and determinants of hyperuricemia in a Belgian multi-ethnic inner-city population of overweight/obese children and adolescents
    
    hrp0095p1-473
  - A National Multicenter Study of Leptin (LEP) and Leptin Receptor (LEPR) Deficiency and a Systematic Review of Patients with Pathogenic LEP/LEPR Variants
    
    hrp0095p1-474
  - The Impact of Acute Exercise on 12,13-Dihydroxy-9Z-Octadecenoic Acid (12,13-DiHOME) Levels in Male Adolescents with Obesity
    
    hrp0095p1-475
  - Do Integrase Inhibitors Alter Body Composition in Young Patients Living with Hiv? The Experience with A Dolutegravir-Based Regimen
    
    hrp0095p1-476
  - Homozygous LEPR mutation as a cause of early onset child hood obesity in a Pakistani girl
    
    hrp0095p1-477
  - The impact of the COVID-19 pandemic, lockdown and school closure on weight and body mass index in low-income children and adolescents with previous overweight in Southern Brazil
    
    hrp0095p1-478
  - 4D-Blood+ Proteomic Profiling of Obesity and Metabolic Syndrome in Adolescents
    
    hrp0095p1-479
  - Clinical symptom and sequence variations in patients with sitosterolemia
    
    hrp0095p1-480
  - Unexpected alterations in thyroid status: a case of alemtuzumab-induced Graves' disease with fluctuating course
    
    hrp0095p1-481
  - Liraglutide SC in the treatment of severe obesity in Pediatrics: a missed therapeutic opportunity?
    
    hrp0095p1-482
  - The ecology of the microbiome in children with congenital generalized lipodystrophy type 4 (CGL4) is quickly modified after metreleptin treatment
    
    hrp0095p1-483
  - Suboptimal adherence to statin therapy in children and adolescents with HeFH despite a high therapeutic efficacy: is the cardiovascular risk underestimated?
    
    hrp0095p1-484
  - Thyroid hormones and food preferences in obese children and adolescents
    
    hrp0095p1-485
- Fetal, Neonatal Endocrinology and Metabolism
- - An Ongoing Phase 2 Study of HM15136, a Novel Long-acting Glucagon Analogue, in Subjects with Congenital Hyperinsulinism (ACHIEVE, Outline Protocol)
    
    hrp0095p1-88
  - A standard operating procedure for prevention, diagnosis, and management of hypoglycaemia in neonates ≥ 35 weeks of gestation
    
    hrp0095p1-89
  - Evaluation of the myokine irisin and adipocytokine leptin content in small for gestational age newborns and their mothers
    
    hrp0095p1-90
  - Global microRNA and protein expression in human term placenta may improve our understanding of fetal growth
    
    hrp0095p1-91
  - Reference National Standards for Placental Weight in Infants born between the 37th and 43rd weeks of Gestation in Qatar. (A Population-Based Retrospective Data Analysis (n = 80722)
    
    hrp0095p1-92
  - Measurements of Growth Hormone in neonatal screening cards as a non-invasive and feasible tool: reference values in healthy term newborns
    
    hrp0095p1-93
  - Adipocytokine status and vitamin D level in large for gestational age newborns
    
    hrp0095p1-94
  - Relationship Between Placental PEG10 Methylation and Postnatal Weight Gain in 6 Year-Old Children
    
    hrp0095p1-95
  - Optimizing Diazoxide dose for the treatment of newborns with hyperinsulinemic hypoglycaemia (HH)
    
    hrp0095p1-96
  - Different types of gastrostomy device in paediatric patients with hyperinsulism
    
    hrp0095p1-97
  - Sulphonylurea for Improving Neurological Features in Neonatal Diabetes: a systematic review and meta-analyses
    
    hrp0095p1-286
  - Hyperinsulinism secondary to PMM2 gene variants: a case series from a quaternary centre reporting associated inflammatory bowel disease and aortopathy
    
    hrp0095p1-287
  - Growth of very low birth weight infants: one year follow-up
    
    hrp0095p1-288
  - Novel Mutations in GLIS3/TRMT10a As A Cause Of Congenital Hyperinsulinism
    
    hrp0095p1-289
  - Impaired renal clearance among Swedish adolescents born preterm
    
    hrp0095p1-290
  - Bronchopulmonary dysplasia is not related to neurofilament light chain for neuroaxonal damage in preterm infants
    
    hrp0095p1-291
  - Management and outcomes of congenital hyperinsulinism in infants and young children: a 5-year-experience from the tertiary referral hospital in IndonesiawGhaisani Fadiana, Frida Soesanti, Aman B Pulungan, Bambang Tridjaja, Jose RL Batubara
    
    hrp0095p1-292
  - Placental Methylation in The IRS1 Gene is Associated with Obesity Parameters in 6 Year-Old Children Born to Mothers with Pre-Gestational Obesity
    
    hrp0095p1-293
  - Foetal and Neonatal outcome of pregnant women with Thyroid Disorders
    
    hrp0095p1-294
  - Continuous Glucose Monitoring for hypoglycaemia: the unheard patient voice
    
    hrp0095p1-295
  - Salivary Sex Steroid Levels in Infants During Minipuberty and Their Relationship with Infantile Colic
    
    hrp0095p1-486
  - Early-Life Exposure to Phthalates in A Population of Infants from The North of Italy: Characterization and Time Trends
    
    hrp0095p1-487
  - Very preterm infants developing BPD have increased levels of the cortisol precursors 17-OH progesterone and 11-deoxycortisol
    
    hrp0095p1-488
  - Longitudinal Growth Pattern in Children Born Large for Gestational Age
    
    hrp0095p1-489
  - Delayed-onset Transient Hyperinsulinism in VLBW and ELBW Neonates
    
    hrp0095p1-490
  - Serum neopterin levels in graves' disease
    
    hrp0095p1-491
  - A Uniquely Mild Presentation of Hyperinsulinemic Hypoglycemia Due to a HADH Mutation (c.709+39C>G) Not Treated with Diazoxide: Long Term Clinical Course
    
    hrp0095p1-492
  - Families' Experiences of Continuous Glucose Monitoring in The Management of Congenital Hyperinsulinism: A Thematic Analysis
    
    hrp0095p1-493
  - Postnatal growth pattern in (n=51) infants of non-diabetic mothers (INDM) who were born preterm or near term and had significant neonatal hypoglycemia
    
    hrp0095p1-494
  - A case report of hyperinsulinemic hypoglycemia caused by a heterozygous novel mutation in the insulin receptor gene
    
    hrp0095p1-495
- GH and IGFs
- - Supporting the mental wellbeing of caregivers of children under growth hormone treatment: mix-methods evaluation of the Adhera® Caring Program
    
    hrp0095p1-98
  - Survey to Investigate Adherence to Growth Hormone Treatment in Children: The Impact of COVID-19 Pandemic
    
    hrp0095p1-99
  - Aetiology of familial short stature in children diagnosed with growth hormone deficiency: what do the genes tell us?
    
    hrp0095p1-100
  - A rare heterozygous IGFI variant causing impaired IGF-I cleavage and postnatal growth failure: a novel disease mechanism with insights into IGF-I physiology
    
    hrp0095p1-101
  - Growth and Growth Delay in Children with Systemic Juvenile Idiopathic Arthritis: A Single Center Study
    
    hrp0095p1-102
  - A novel IGF1R variant in a child with mild IGF1 resistance, normal birth weight, mild short stature and microcephaly
    
    hrp0095p1-103
  - SARS-CoV-2 pandemic and GH treatment: new strategies to abate the distance
    
    hrp0095p1-104
  - Early Growth Failure and Untreated Growth Hormone Deficiency in Radiotherapy-Treated Long-Term Survivors of Childhood Brain Tumor
    
    hrp0095p1-105
  - Shox Deficiency in Children with Short Stature: Response To Recombinant Growth Hormone Therapy (rGH)
    
    hrp0095p1-106
  - No differences in adult height outcome with personalized approach to Growth Hormone dosing– but gender differences were found
    
    hrp0095p1-296
  - rhGH therapy in a patient with homozygous IGF1R mutation
    
    hrp0095p1-297
  - Use of PDE5 inhibitors as a potential treatment for isolated growth hormone deficiency caused by alternate splicing of GH1 gene
    
    hrp0095p1-298
  - Impact of body composition on skeletal health in subjects with Klinefelter's syndrome: a cross sectional study
    
    hrp0095p1-299
  - Evaluation of the growth response of children with growth hormone deficiency according to peak growth hormone levels on provocative tests
    
    hrp0095p1-300
  - High prevalence of refractoriness in children tested for growth hormone deficiency with nocturnal spontaneous profile and subsequent arginine-insulin-tolerance test
    
    hrp0095p1-301
  - Patients' adherence and satisfaction from daily vs monthly vitamin D supplementation: results from a dedicated bone clinic
    
    hrp0095p1-302
  - Short stature due to a novel missense variant (695C>A) in the GHR gene: a case report
    
    hrp0095p1-303
  - Growth hormone deficiency and central hypothyroidism related to microarray abnormality involving a loss of ~111-kilobases (kb) within cytogenetic band Xq28 and a gain within cytogenetic band 20q11.22
    
    hrp0095p1-304
  - The Effect of Anastrozole Treatment on Height Gain in Pubertal Boys on Growth Hormone Treatment
    
    hrp0095p1-496
  - Metabolomics profile of children with growth hormone deficiency
    
    hrp0095p1-497
  - A Long-Acting Growth Hormone Module For Paediatric Growth Hormone Deficiency In The Global Registry For Novel Therapies In Rare Bone & Endocrine Conditions – The GloBE-Reg LAGH Study
    
    hrp0095p1-498
  - Long-term safety and effectiveness of recombinant human growth Hormone inKorean pediatric patients with growth disorders: 9-year interim analysis fromLG Growth Study
    
    hrp0095p1-499
  - A patient-centric approach to connected health solutions in paediatric growth hormone therapy
    
    hrp0095p1-500
  - IGFBP-3 assessment in the work-up of short stature
    
    hrp0095p1-501
  - A real life evaluation of rhGH efficacy in children born SGA
    
    hrp0095p1-502
  - Adult Height in Patients with Non-Permanent, Idiopathic and Isolated Growth Hormone Deficiency
    
    hrp0095p1-503
  - easypod Augmented Reality: Usability and acceptability of a virtual reality mobile solution to support training of patients on a connected injection device
    
    hrp0095p1-504
- Growth and Syndromes
- - Identifying several patient-related factors that predicted permanent growth hormone deficiency (GHD)
    
    hrp0095p1-107
  - Efficacy, Observer-Reported Outcomes, and Safety of Once-Weekly Somapacitan in Children with Growth Hormone Deficiency (GHD): 4-Year Results from the REAL 3 Trial
    
    hrp0095p1-108
  - Efficiency of The Genetic Study in the Assessment of Short Stature in Pediatrics
    
    hrp0095p1-109
  - Characterisation of the first heterozygous missense HMGA2 variant helps delineate the crucial functional roles of a novel growth gene
    
    hrp0095p1-110
  - Analysis of the nutritional status of women in twin pregnancies in terms of key vitamins and microelements - preliminary results
    
    hrp0095p1-111
  - Long-term follow-up of aromatase-inhibitor use in 3 family members with aromatase excess syndrome
    
    hrp0095p1-112
  - Development and testing of a novel ‘GrowthMonitor’ Smartphone App for growth monitoring and the detection of growth disorders
    
    hrp0095p1-113
  - Metabolic Status in Prepubertal and Pubertal Children with Turner Syndrome
    
    hrp0095p1-114
  - Validation of referral criteria for growth monitoring in Flanders based on height at the start of GH therapy in children with growth hormone deficiency and Turner syndrome
    
    hrp0095p1-115
  - Clinical and biochemical parameters of puberty onset in children with Silver Russell syndrome and children born small for gestational age
    
    hrp0095p1-116
  - The elevated levels of Fetuin-A and FGF21 are correlated with metabolic indicators in Turner syndrome
    
    hrp0095p1-117
  - A background review of several generic patient-reported outcome and clinician-reported outcome measures: Selecting measures for further evaluation in a qualitative study in achondroplasia
    
    hrp0095p1-118
  - Post-hoc subgroup analysis of Asian subjects from the pivotal phase 3 study of once-weekly somatrogon vs once-daily Genotropin
    
    hrp0095p1-119
  - Mosaic sex chromosomal abnormalities in male individuals with short stature: a new role for non-conventional techniques (whole exome sequencing, genome wide array analysis, SHOX MLPA) in making the genetic diagnosis
    
    hrp0095p1-120
  - Qatar National standards for newborn weight
    
    hrp0095p1-121
  - A Case of Derivative Chromosome 1 Accompanied by Y Chromosome Deletion
    
    hrp0095p1-122
  - Single center analysis of the characteristics of 24-hour ambulatory blood pressure and related factors in patients with Turner syndrome
    
    hrp0095p1-123
  - Analysis of Clinical Features and Causative Genes in 48 Children with Short Stature of Unknown Etiology
    
    hrp0095p1-124
  - SHOX gene deletion as part of a contiguous gene syndrome at Xp22.31p22.33 deletions
    
    hrp0095p1-125
  - Earlier menarche of mothers as a risk factor for daughters’ early age at menarche and short stature in young Korean females: an epidemiologic study
    
    hrp0095p1-126
  - Treatment response to growth hormone in a patient with heterozygous ROR2 mutation
    
    hrp0095p1-127
  - Major opinion about motherhood among women with Turner Syndrome – International online survey
    
    hrp0095p1-128
  - Variegated Mosaic Aneuploidy Syndrome in Two Severely Undersized Siblings
    
    hrp0095p1-129
  - Osteogenesis imperfecta / Ehlers–Danlos (OI/EDS) overlap syndrome associated with a new COL1A1 variant (c.3235G>A, p.Gly1079Ser) in a girl with severe short stature and neuroblastoma
    
    hrp0095p1-130
  - SHORT syndrome in a twelve-year old boy-case report
    
    hrp0095p1-131
  - The Study of Growth in Thalassemic Patient
    
    hrp0095p1-132
  - Postnatal growth of infants born < 2.5 kg: small for gestational age (SGA) vs appropriate for gestational age (AGA)
    
    hrp0095p1-133
  - Applying personalized medicine- From a unique endo-genetic clinic to a national project of certifying endocrinologists to perform genetic consults and testing
    
    hrp0095p1-134
  - Once-Weekly Somapacitan vs Daily Growth Hormone in Children Born Small for Gestational Age: 1-year Results from a Randomised Phase 2 Trial
    
    hrp0095p1-305
  - Bone age in children with achondroplasia
    
    hrp0095p1-306
  - A Prospective Clinical Trial of Vosoritide in Hypochondroplasia: Baseline Demographics and Preliminary Results
    
    hrp0095p1-307
  - Postnatal growth failure of aggrecan deficient mice is due to impaired growth plate chondrogenesis
    
    hrp0095p1-308
  - International Standard Growth Charts Overestimates Stunting Prevalence in Indonesia Compared to the Indonesian National Growth Chart
    
    hrp0095p1-309
  - The Prader-Willi phenotype and atypical 15q11.2-q13 deletions
    
    hrp0095p1-310
  - Oxidative stress decreased after six months testosterone treatment compared to placebo in ageing men - a randomized, double-blind trial
    
    hrp0095p1-311
  - Global Increlex^® Registry, post-authorisation surveillance registry monitoring the long-term safety and effectiveness of mecasermin in children and adolescents with Severe Primary IGFD (SPIGFD): objectives and study design
    
    hrp0095p1-312
  - Pathway to assess severe primary IGF-1 deficiency diagnosis in a real-life setting: data from the Global Increlex^® Registry
    
    hrp0095p1-313
  - Klinefelter Syndrome: Clinical Spectrum Based on 21 years experience of a Pediatric Endocrinology Unit
    
    hrp0095p1-314
  - A Novel PADI6 Variant as a Cause of Recurrent Miscarriage and Multi Locus Imprinting Disturbance within the same family
    
    hrp0095p1-315
  - Simultaneous pancreas-kidney transplantation: long-term survival and metabolic profile analysis among functioning pancreatic graft patients - A 20 year experience from a center in Portugal
    
    hrp0095p1-316
  - Effects of combined treatment with rhIGF-I and metreleptin in a girl with the severe insulin resistance Rabson-Mendenhall syndrom
    
    hrp0095p1-317
  - The molecular study of Ras/MAPK pathway and treatment of short stature in Noonan syndrome
    
    hrp0095p1-318
  - Analysis of trabecular bone score in girls with Turner syndrome
    
    hrp0095p1-319
  - International vs Qatar national growth data for identifying small and large-for-gestational-age newborns: A population-based study in Qatar
    
    hrp0095p1-320
  - A Novel IGF2 Gene Variant of Paternal Origin Causing the Silver-Russell Syndrome Phenotype
    
    hrp0095p1-321
  - Analysis of genetic variability in 134 women with Turner Syndrome using high-throughput next-generation sequencing
    
    hrp0095p1-322
  - Assessment of linear growth and weight gain after early infantile surgical repair of tetralogy of Fallot (TOF)
    
    hrp0095p1-323
  - The diagnosis of aortic dilatation in Chinese children and adolescents with Turner syndrome
    
    hrp0095p1-324
  - ERF mutation in a patient with Noonan-like phenotype, type 1 diabetes mellitus and epilepsy
    
    hrp0095p1-325
  - The relationship of the physical development of erosive gastroesophageal reflux disease in children
    
    hrp0095p1-326
  - A comprehensive assessment of patient-reported outcome measures in children and parents of children with achondroplasia: Results from a qualitative research and mapping exercise
    
    hrp0095p1-327
  - A real-world study of persistence with daily growth hormone therapy among children with growth hormone deficiency in Japan
    
    hrp0095p1-328
  - Associations between Eating Patterns of Adolescents and Their Height and Weight, A Comparison Between Genders
    
    hrp0095p1-329
  - The JAMP (Journey around Achondroplasia Medicines and Patients) Project: Results Collected From Two Surveys to Clinicians and Patients in Italy
    
    hrp0095p1-330
  - Prevalence of Obesity from birth to 3 years of age in infants born large for date (LGA): Infants with weight for age (WAZ) catch down vs those without catch down during the first year of life
    
    hrp0095p1-331
  - Growth Hormone Therapy Experience in a Patient with Hypotonia Cystinuria Syndrome
    
    hrp0095p1-332
  - The effects of one year of growth hormone treatment on growth and body composition in patients with Temple syndrome
    
    hrp0095p1-505
  - A service evaluation on the management of Noonan syndrome in the West of Scotland
    
    hrp0095p1-506
  - Vosoritide Improves Growth in Noonan Syndrome and Patients with NPR2 Mutations
    
    hrp0095p1-507
  - Real-world experience with Vosoritide for achondroplasia: interim findings from an early access programme in France
    
    hrp0095p1-508
  - Breast Satisfaction in adult women with Turner Syndrome – an international survey employing the BREAST-Q questionnaire
    
    hrp0095p1-509
  - Temple syndrome: clinical findings and body composition
    
    hrp0095p1-510
  - Clinical characterization of patients with SHOX variants regarding their functional classification
    
    hrp0095p1-511
  - Physical Activity: An Underestimated Factor in the Management of Arterial Hypertension in Women with Turner-Syndrome?
    
    hrp0095p1-512
  - The first reported pregnancy and birth by a patient affected by Alstrom Syndrome: a case report
    
    hrp0095p1-513
  - Abstract unavailable
    
    hrp0095p1-514
  - Distinct Growth Characteristics in Angelman Syndrome
    
    hrp0095p1-515
  - Ovarian hilus cell hyperplasia: a rare cause of progressive virilization in a girl with Turner syndrome in the absence of Y chromosomal material
    
    hrp0095p1-516
  - Evaluation of Genetic Etiology in Children Born Small for Gestational Age with Persistent Short Stature: Preliminary Results
    
    hrp0095p1-517
  - Laboratory evidence of hyperaldosteronism is common in patients with kidney stones - a retrospective single-center analysis
    
    hrp0095p1-518
  - Brain Structure in a cohort of young adult patients with Autoimmune Addison's Disease
    
    hrp0095p1-519
  - A Case of Familial Short Stature: A Novel Variant of ACAN
    
    hrp0095p1-520
  - Case with Hoxa Gene Cluster Delete
    
    hrp0095p1-521
  - Positive impact of the TuiTek® patient support programme on caregivers of patients receiving treatment for growth hormone deficiency in Argentina
    
    hrp0095p1-522
  - The diagnosis of aortic dilatation in Chinese children and adolescents with Turner syndrome
    
    hrp0095p1-523
  - A Case with Growth and Developmental Retardation: 12q14 Deletion
    
    hrp0095p1-524
  - Growth Hormone IGF-1 axis and treatment with Growth Hormone in PGM1 deficiency
    
    hrp0095p1-525
  - A Case of Short Stature Presenting with Multiple Exocytosis
    
    hrp0095p1-526
  - The Cumulative incidence of SGA, AGA and LGA, Premature, Postmature, and Term birth in infants born between the 33rd weak and the 44th weeks of Gestation in Qatar
    
    hrp0095p1-527
  - The SHOX gene between duplication and deletion: when the follow-up guides the treatment
    
    hrp0095p1-528
  - A case of Silver Russell Syndrome-like phenotype with abnormal methylation of the imprinted GNAS locus (20q13)
    
    hrp0095p1-529
  - Proportions of abnormal growth parameters in extremely low birth weight infants (ELBW) during the first 3 years of life: weight Z score(WAZ), length Z score (LAZ), weight for length Z score (WLZ), and head circumference Z score (HCZ)
    
    hrp0095p1-530
  - Long-term efficacy and safety of pasireotide in patients with Cushing's disease: a monocentric experience
    
    hrp0095p1-531
  - Cerebral aneurysms and kidney disease in a child with microcephalic osteodysplastic primordial dwarfism type II: novel homozygous mutation in the PCNT gene
    
    hrp0095p1-532
  - Central Precocious Puberty in McCune Albright Syndrome: a case report
    
    hrp0095p1-533
- Multisystem Endocrine Disorders
- - Hypoaldosteronism without hypocortisolism - an unusual presentation of APECED syndrome
    
    hrp0095p1-135
  - Time Taken to Reach a Diagnosis In Children With XY DSD In Expert Endocrine Centres In Europe
    
    hrp0095p1-136
  - First description of a child with a biallellic loss-of-function variant in the sulfate transporter SLC13A1
    
    hrp0095p1-137
  - Takayasu's artheritis presenting as a large sellar mass with neurological and hypopituitarism manifestations
    
    hrp0095p1-138
  - “Cushing’s syndrome in a girl with Carney Complex: a case report”
    
    hrp0095p1-139
  - Prevalence of Endocrinopathies in Sickle cell Disease Patients on Conventional Therapy: Review of literature in the past 25 years
    
    hrp0095p1-140
  - A Case with Primrose Syndrome and What He Taught
    
    hrp0095p1-141
  - Two causes of short stature and delayed puberty in one patient: craniopharyngioma and celiac disease. A case report
    
    hrp0095p1-142
  - Emerging phenotypes linked to variants in SAMD9 and MIRAGE syndrome
    
    hrp0095p1-333
  - Multi-continent comparison of the prevalence of short stature and undernutrition in children and adolescents with homozygous sickle cell disease: Africa, USA, Europe, and Middle East area
    
    hrp0095p1-334
  - Early endocrinological deficiencies can anticipate the diagnosis of mitochondrial diseases: phenotype evolution of a rare MT-TG gene variant
    
    hrp0095p1-335
  - Prevalence of Short Stature and Endocrinopathy in β-thalassemia Major Patients on Conventional Therapy in the Mediterranean and the Middle East countries
    
    hrp0095p1-336
  - Alopecia totalis at the onset of polyglandular syndrome type
    
    hrp0095p1-337
  - Age of Estrogen Therapy Affects on Final Height in Girls with Chronic Kidney Disease and Short Stature
    
    hrp0095p1-338
  - Treatment-resistant hypokalemia and arterial hypertension: a prismatic case of low renin childhood hypertension
    
    hrp0095p1-339
  - A novel SPINT2 missense mutation（c.386A>G;p.Y129C）causes syndromic congenital sodium loss diarrhea: The first case report in China
    
    hrp0095p1-340
  - Successful treatment of neonatal Cushing in a paediatric patient with McCune Albright Syndrome (MAS) by using metyrapone suppositories
    
    hrp0095p1-534
  - Case Report: HAX1 Mutation/Kostmann Syndrome: A close cooperation between pediatric endocrinologists and hem-oncologists is crucial!
    
    hrp0095p1-535
  - A case of septo-optic dysplasia and congenital hypothyroidism in a patient affected by Zhu-Tokita-Takenouchi-Kim (ZTTK) syndrome
    
    hrp0095p1-536
  - A case report of Pituitary Stalk Interruption Syndrome caused by novel compound heterozygous mutations in the KATNIP gene
    
    hrp0095p1-537
  - Capillary Hyperglycemia in Infants - A manifestation of endocrinological urgency, or not
    
    hrp0095p1-538
  - Rett Syndrome Patients: Do They need Pediatric Endocrinologist’s care?
    
    hrp0095p1-539
  - Screening for hypoparathyroidism in beta thalassemia major: About a series from Constantine
    
    hrp0095p1-540
  - Severe Systemic Pseudohypoaldosteronism Type 1: 10 years of evolution
    
    hrp0095p1-541
- Pituitary, Neuroendocrinology and Puberty
- - Use of the 100,000 Genomes Project to identify the molecular basis of rare endocrine disorders within a tertiary paediatric endocrinology centre
    
    hrp0095p1-143
  - Precocious puberty and other pubertal disorders in females during the Italian lockdown and the coronavirus 2019 (COVID-19) pandemic
    
    hrp0095p1-144
  - Spatial navigation and memory in transgender male adolescents treated with gender affirming hormones
    
    hrp0095p1-145
  - Spectrum of Endocrinopathy in Children with Ectopic Posterior Pituitary (EPP)
    
    hrp0095p1-146
  - Prevalence of Polycystic Ovarian Syndrome (PCOS) In Girls with History of Idiopathic Central Precocious Puberty (ICPP)
    
    hrp0095p1-147
  - Usefulness of Next Generation Sequencing in the Molecular Diagnosis of McCune-Albright Syndrome in Peripheral Blood
    
    hrp0095p1-148
  - Validation of Puberty Interpreter, a mobile application-based evaluation of pubertal disorders
    
    hrp0095p1-149
  - Pubertal dysfunctions in intracranial germ cell tumours
    
    hrp0095p1-150
  - The effect of a GnRH analogue injection on the circulating levels of kisspeptin-1 in girls with suspected central precocious puberty
    
    hrp0095p1-151
  - COVID-19 and precocious puberty: Does BMI play a role?
    
    hrp0095p1-152
  - Subtype-specific pattern of white blood cell differential in endogenous Cushing's syndrome
    
    hrp0095p1-153
  - Reference values in pelvic ultrasonography for a Spanish population of healthy girls between 6 and 12 years old
    
    hrp0095p1-154
  - Evaluation of the influence of the gonadotropin-releasing hormone agonist therapy on growth and body mass index in girls with idiopathic central precocious puberty
    
    hrp0095p1-155
  - Cushing´s disease in children and adolescents: Experience of a single tertiary center
    
    hrp0095p1-156
  - Effect of gonadotropin-releasing hormone agonist monotherapy and combination therapy with growth hormone on final adult height in girls with central precocious puberty
    
    hrp0095p1-157
  - Clinical Findings and Endocrine Follow-up of Childhood Craniopharyngioma Cases
    
    hrp0095p1-158
  - Final adult height and bone mineral density of the children who were treated with gonadotropin releasing hormone analogues near the age eight
    
    hrp0095p1-159
  - Central diabetes insipidus following immunization with anti-COVID19 BNT162b2 Comirnaty vaccine
    
    hrp0095p1-160
  - Causal Effect of Age at Menarche on the Risk for Depression: Results from a Two-Sample Multivariable Mendelian Randomization Study
    
    hrp0095p1-161
  - Complications of non-endocrine pituitary tumors in children, in the city of Oran
    
    hrp0095p1-162
  - Stress and Hyperprolactinemia: Can a Stimulation Test be Used to Evaluate?
    
    hrp0095p1-163
  - Familial Central Precocious Puberty: a case of three siblings with MKRN3 mutation
    
    hrp0095p1-164
  - The Effect of Metformin on the Onset of Menarche and The Final Height of Obese Girls
    
    hrp0095p1-165
  - Metabolic setup in infants with panhypopituitarism
    
    hrp0095p1-166
  - Patient-reported outcomes (PRO) in adult growth hormone deficiency (aghd) for an improved patients' management: results from the management of AGHD(MAGHD) study
    
    hrp0095p1-167
  - Are Obese Cases with Precocious Puberty Diagnosed Late?
    
    hrp0095p1-168
  - Proposal of a diagnostic flow-chart for the diagnosis of central precocious puberty (CPP) in females
    
    hrp0095p1-341
  - Redefinition of LH Cut-Off to Earlier Diagnose Evolutive Precocious Puberty After Triptorelin Stimulation Test
    
    hrp0095p1-342
  - Subcutaneous Triptorelin stimulation test for diagnosing central precocious puberty in girls
    
    hrp0095p1-343
  - Puberty patterns in boys with X-linked congenital adrenal hypoplasia
    
    hrp0095p1-344
  - A cause of familial central precocious puberty: A Novel variant in the DLK1 gene and low serum DLK1 levels
    
    hrp0095p1-345
  - In between isolated premature thelarche and central precocious puberty: when DHEAS makes the difference
    
    hrp0095p1-346
  - Congenital hypogonadotropic hypogonadism and Cornelia de Lange Syndrome share clinical phenotype and genetic background
    
    hrp0095p1-347
  - A homozygous Y443C variant in the RNPC3 is associated with severe syndromic congenital hypopituitarism and diffuse brain atrophy
    
    hrp0095p1-348
  - Use of Urinary Gonadotropins for The Evaluation of the Minipubertal Profile in Term Newborns and Infants Within The First Six Months of Age
    
    hrp0095p1-349
  - Prevalence of autoantibodies in paediatric and adult patients with type 1 diabetes mellitus - study of a Portuguese cohort
    
    hrp0095p1-350
  - Evaluation of Early Puberty in Patients with MC2R Deficiency
    
    hrp0095p1-351
  - Random Luteinizing Hormone Concentrations for Monitoring Central Precocious Treatment Efficacy
    
    hrp0095p1-352
  - A novel missense variant in the gene encoding Fatty Acid Synthase (FASN) associated with a unique multi-system disorder including hypopituitarism and hypoparathyroidism
    
    hrp0095p1-353
  - Single centre experience of using 6 monthly GnRH analogues in the paediatric population
    
    hrp0095p1-354
  - Serum Ghrelin and Neuropeptide Y Concentrations and Their Relationship with Gonadotropins and Anthropometric Parameters in Girls with Idiopathic CEntral Precocious Puberty, Premature Thelarche and Premature Adrenarche
    
    hrp0095p1-355
  - Use of The Arginine-Stimulated Copeptin Test in Polyuric Syndrome in Paediatrics. Experience in Three Patients
    
    hrp0095p1-356
  - The Prolactin (PRL) – Growth Hormone (GH) Relationship during Growth Hormone Stimulation Tests
    
    hrp0095p1-357
  - Pathogenic and Low-Frequency genetic determinants in children with Central Precocious Puberty
    
    hrp0095p1-358
  - Primary Granulomatous Hypophysitis with Panhypopituitarism, presenting as Aseptic Meningitis in a 14-year-old boy
    
    hrp0095p1-359
  - Somatostin analogs in a 15 year old boy with gigantism
    
    hrp0095p1-360
  - Blue Light Exposure and Exposure Duration Effects on Rats' Puberty Process
    
    hrp0095p1-361
  - Negative impact of brain tumors on the neurocognitive functions of childhood cancer survivors
    
    hrp0095p1-362
  - Medium-and long-term follow-up observation of the efficacy and safety of GnRHa in the treatment of five cases of central precocious puberty caused by hypothalamic hamartoma
    
    hrp0095p1-363
  - Pneumonia as the first manifestation of pediatric pulmonary carcinoid tumor
    
    hrp0095p1-364
  - Etiology and Clinical Features in Childhood Panhypopituitarism
    
    hrp0095p1-365
  - Hemorrhagic pituitary apoplexy due to pituitary adenoma: description of two cases in two adolescent males
    
    hrp0095p1-366
  - Clinical Manifestation and Treatment Outcomes of Pheochromocytoma and Paraganglioma in Children and Adolescents : A 26-year Single- Center Experience
    
    hrp0095p1-542
  - Whole blood transcriptomic profile of Cushing's syndrome
    
    hrp0095p1-543
  - Long term effects of continuous subcutaneous infusion of recombinant LH and FSH during infancy on testicular function in congenital hypogonadotropic hypogonadism
    
    hrp0095p1-544
  - X-Linked Central Precocious Puberty Associated with MECP2 defects
    
    hrp0095p1-545
  - Change of menarcheal age in schoolgirls living in Istanbul over the last 12 years
    
    hrp0095p1-546
  - Project to improve paediatric post-neurosurgical fluid management and to reduce the risks associated with Diabetes Insipidus (DI), Syndrome of Inappropriate ADH (SIADH) and Cerebral Salt Wasting (CSW).
    
    hrp0095p1-547
  - Legal degree of disability in childhood-craniopharyngioma survivors during long-term follow-up: Results of the HIT-ENDO study
    
    hrp0095p1-548
  - Genetic causes of combined pituitary hormone deficiency
    
    hrp0095p1-549
  - Clinical description of ten paediatric patients with rapid-onset obesity and clinical signs of ROHHAD-NET Syndrome
    
    hrp0095p1-550
  - Impact of the COVID 19 pandemic on the incidence of precocious puberty
    
    hrp0095p1-551
  - Final adult height in children with central precocious puberty – a retrospective study
    
    hrp0095p1-552
  - Evaluation of the Frequency of Multiple Hormone Deficiency and Long-Term Data in Patients with Craniopharyngioma
    
    hrp0095p1-553
  - Oligogenic Inheritance May Explain The Phenotypic Variability and Incomplete Penetrance of Deleterious GL1I2 Variants in Congenital Hypopituitarism
    
    hrp0095p1-554
  - Management Options for Adolescents with Abnormal Uterine Bleeding, according to their Demographic, Clinical and Laboratory Characteristics
    
    hrp0095p1-555
  - Surprisingly high frequency of pituitary stalk thickening in pediatric patients during COVID-19 pandemic in Chile
    
    hrp0095p1-556
  - Pituitary tuberculosis and hypothalamic obesity can be reversed by prolonged anti-tuberculosis treatment
    
    hrp0095p1-557
  - Simultaneous quantification of 51 steroids in pediatric plasma and urine samples by LC–MS/MS
    
    hrp0095p1-558
  - Extreme hypercalcemia due to primary hyperparathyroidism- a look-back on over a decade in a tertiary care center
    
    hrp0095p1-559
  - Craniopharyngiomas in children: Hormonal profile and regional complications
    
    hrp0095p1-560
  - A new DLK1 defect in a family with idiopathic CPP: elucidation of the male phenotype
    
    hrp0095p1-561
  - DNA methylation status of MKRN3 in puberty: studies in Central Precocious Puberty girls and in pubertal mouse
    
    hrp0095p1-562
  - Transient multiple pituitary hormone deficiency in critically ill pediatric patients
    
    hrp0095p1-563
  - Adenohypophyseal Hyperfuction in Childeren and Adolescents with McCune-Albright Syndrome
    
    hrp0095p1-564
  - Adult Height is impaired in females with Medulloblastoma and hypogonadism: Impact of Pubertal Timing
    
    hrp0095p1-565
  - Cystic Giant Prolactinoma in Childhood:
    
    hrp0095p1-566
- Sex Differentiation, Gonads and Gynaecology, and Sex Endocrinology
- - Analysis of the GHR gene poly¬morphism in a non-disgenetic 46,XY DSD cohort without molecular diagnosis
    
    hrp0095p1-169
  - Increased Circulating Levels of Myo-inositol in Girls with Polycystic Ovary Syndrome
    
    hrp0095p1-170
  - Predictors of surgical outcomes in boys with hypospadias
    
    hrp0095p1-171
  - Diabetes type 1 can induce testicular atrophy with Leydig cell hyperplasia and germ cell depletion and therefore prevents reproductive function and fertility in rats
    
    hrp0095p1-172
  - Differences due to the variant type in the inheritance pattern of BMP15 gene-related primary ovarian insufficiency: a girl with a homozygous null BMP15 gene variant
    
    hrp0095p1-173
  - A rare case of male sex reversal syndrome (46,XX) with negative SRY gene: a disorder of sexual differentiation (DSD)
    
    hrp0095p1-174
  - Primary Ovarian Failure as a Result of Homozygous Mutations in MCM10 Gene
    
    hrp0095p1-175
  - Diagnostic and management practices of girls presenting with polycystic ovary syndrome (PCOS)-like symptoms to a tertiary paediatric endocrine clinic
    
    hrp0095p1-176
  - Empower-DSD: Development of a patient education programme for children, adolescents, and young adults with differences of sex development (DSD) and their parents
    
    hrp0095p1-177
  - Human chorionic gonadotropin (hCG)–secreting hepatoblastoma in an male infant with peripheral precocious puberty and 11-year follow-up
    
    hrp0095p1-178
  - Loss of function of FIGNL1, a DNA damage response gene, is a novel cause of human ovarian dysgenesis
    
    hrp0095p1-179
  - The lifetime cost of reproductive potential – who spends the most?
    
    hrp0095p1-180
  - Monoallelic variants in Myelin Regulatory Factor (MYRF) associated with 46,XY DSD – two cases and first report of inheritance through parental mosaicism
    
    hrp0095p1-181
  - Abstract unavailable
    
    hrp0095p1-182
  - Testicular sperm extraction in a patient with a new pathogenic NR5A1 (SF-1) variant : p.Phe70Serfs*5
    
    hrp0095p1-183
  - Cerebello- Oculo- Fascio-Genital Syndrome and Scrotal Agenesis with MAB21L1 Mutation; Case Report
    
    hrp0095p1-184
  - Puberty induction in boys with CHARGE syndrome and hypogonadism: experiences of patients, parents and doctors
    
    hrp0095p1-185
  - Inflammation and polycystic ovary syndrome (PCOS). Utilising proteomic analysis to unravel the link between inflammatory proteins and PCOS in adolescents
    
    hrp0095p1-186
  - Evaluation of The Relationship Between the Immune and Endocrine System in Children Diagnosed with Polycystic Ovary Syndrome
    
    hrp0095p1-367
  - Gender dimorphism in transgender youth – hormonal therapy and the balance between muscle, adipose tissue and cardiometabolic alterations
    
    hrp0095p1-368
  - Prevalence of Overweight and Obesity in a Transgender Youth Cohort
    
    hrp0095p1-369
  - An Investigation Of Androgen-responsive Non-coding RNAs In Boys With Atypical Genitalia Without Genetic Variants in the Androgen Receptor (AR)
    
    hrp0095p1-370
  - Exome sequencing reveals a high proportion of causal and candidate gene variants in a large early-onset Primary Ovarian Insufficiency cohort
    
    hrp0095p1-371
  - Impact of diabetes mellitus on patients' quality of life
    
    hrp0095p1-372
  - A novel Androgen Receptor mutation causes complete androgen receptor insensitivity syndrome with gender dysphoria and unusual postnatal androgen profile
    
    hrp0095p1-373
  - Is testosterone supplementation required after induction of puberty in Duchenne muscular dystrophy? A follow-up study
    
    hrp0095p1-374
  - Effects of long-term puberty suppression and gender-affirming hormones on body composition and metabolic profile in a preclinical mouse model and a cohort of transboys
    
    hrp0095p1-375
  - A virilizing ovarian tumour following previous rhabdomyosarcoma, masking ovarian failure
    
    hrp0095p1-376
  - Novel genomic variants, atypical phenotypes and evidence of a digenic/oligogenic contribution to Disorders/Difference of Sex Development in a large north African cohort
    
    hrp0095p1-377
  - Assessment Of External Genitalia Change Over Time In Boys With XY Disorder Of Sex Development (DSD)
    
    hrp0095p1-378
  - The effect of timing of puberty suppression on breast development in trans girls; a cross-sectional study
    
    hrp0095p1-379
  - Effect of Long Acting Gonadotropin Releasing Hormone Agonists on Height Outcome in Children
    
    hrp0095p1-380
  - Gynaecomastia And Its Management In Partial Androgen Insensitivity Syndrome (PAIS)
    
    hrp0095p1-381
  - Accidental transdermal estradiol exposure leading to gynecomastia and bone age acceleration in a 7 year old boy: a case presentation
    
    hrp0095p1-382
  - Study of Quality of Life among Children with Congenital Adrenal Hyperplasia at Alexandria University Children’s Hospital
    
    hrp0095p1-383
  - 17 Β-Hydroxysteroid Dehydrogenase Type 3 Deficiency Diagnosed in Early Childhood
    
    hrp0095p1-384
  - A Rare and Treatable Cause of Prepubertal Gynecomastia: Large Cell Calcifying Sertoli Cell Tumor
    
    hrp0095p1-385
  - Two Cases with Hypergonadotropic Hypogonadism Due to Derivative X Chromosome
    
    hrp0095p1-567
  - Endocrine care for gender incongruent children and adolescents in The Czech Republic between 2011-2020
    
    hrp0095p1-568
  - Abstract unavailable
    
    hrp0095p1-569
  - Does your daughter have a larger than usual clitoris”? Parental perception of CAH management outcome
    
    hrp0095p1-570
  - Detection of Copy Number Variations by Microarray in Disorders of Sex Development of Unexplained Molecular Etiology and Association with Clinical Findings
    
    hrp0095p1-571
  - Long-term GnRHa use and bone health in transgender adolescents: can a mouse model inform clinical practice?
    
    hrp0095p1-572
  - Long-term follow-up of DHH variant-caused 46, XY disorders of sex development with multiple complications in a Chinese Child
    
    hrp0095p1-573
  - Phenotype-genotype characteristics of SRD5A2 with variation in gender choice among affected individuals: A single centre experience
    
    hrp0095p1-574
  - A novel mutation in the BMP15 gene in a Palestinian family with primary amenorrhea revealing molecular genetics of premature ovarian insufficiency
    
    hrp0095p1-575
  - Relationship between environmental effects and metabolic characteristics of partial and central precocious puberty in girls: Understanding pathogenesis and identifying specific biomarkers
    
    hrp0095p1-576
  - Pediatric transgender care from an endocrine perspective: experience over the past decade in a tertiary Swiss center
    
    hrp0095p1-577
  - Results of Gonadotropin and Testosterone Treatments in Male Cases Diagnosed with Hypogonadotropic Hypogonadism: A Single Center Experience
    
    hrp0095p1-578
  - MCM9 mutation in a case of premature ovarian insufficiency with vitiligo
    
    hrp0095p1-579
  - A rare case of 46,XY difference of sexual development (DSD) due to combined homozygous CYP17A1 and heterozygous CYP21A2 mutations with a unique phenotype and hormone profile
    
    hrp0095p1-580
  - A case series of granulosa cell tumors of the ovary
    
    hrp0095p1-581
  - An International Study Of The Association Between Local Health Care Resources And Acute Adrenal Insufficiency Events In Children With Congenital Adrenal Hyperplasia
    
    hrp0095p1-582
  - Androgen receptor activity in genital skin fibroblasts in response to dihydrotestosterone, testosterone and androstenedione using the APOD assay
    
    hrp0095p1-583
  - A Late Reperfused Ovarian Torsion Diagnosed as Acute Appendicitis in a Prepubertal Case
    
    hrp0095p1-584
  - Long Term Follow-up of A Boy Who Had Suprasella Tumor Recurrence 4 Years After the First Diagnosis of Extracranial GCTs
    
    hrp0095p1-585
- Thyroid
- - Analysis of miR-15a-5p, miR-126-3p, miR-142-5p and miR-150-5p levels in blood of children and adolescents with thyroid diseases
    
    hrp0095p1-187
  - A case report of Hirschsprung Disease and C Cell Hyperplasia: a new RET gene variant?
    
    hrp0095p1-188
  - Resistance to Thyroid Hormone β in an infant with a novel de novo mutation of the THRB gene
    
    hrp0095p1-189
  - Genetic spectrum of 26 Korean patients with congenital hypothyroidism by targeted next-generation sequencing
    
    hrp0095p1-190
  - Hyperthyroidism leading to Idiopathic Intracranial Hypertension in a Child – A Case Report
    
    hrp0095p1-191
  - Simulation via instant messaging − birmingham advance (SIMBA) as a tool to bridge gaps in clinical knowledge and expectations between physicians and patients with polycystic ovary syndrome
    
    hrp0095p1-192
  - Diagnostic Features and Risk Factors for Childhood Thyroid Cancers
    
    hrp0095p1-193
  - Response to initial treatment in a pediatric cohort of patients with papillary thyroid cancer (PTC): changes after 3 years of follow up
    
    hrp0095p1-194
  - Molecular Characterisation of Patients with Thyroid Dyshormonogenesis and Variants in DUOX2
    
    hrp0095p1-195
  - Diffuse Sclerosing Variant of Papillary Thyroid Cancer in a boy with Goldenhar Syndrome
    
    hrp0095p1-196
  - A familial case of PAX8 gene variant with incomplete penetrance
    
    hrp0095p1-197
  - FT3:FT4 ratio be used to predict relapse and remission? Single Centre Experience
    
    hrp0095p1-198
  - Thyroid Hormone Receptor Resistance Alpha: Case Report
    
    hrp0095p1-199
  - Severe and Non Severe Forms of Autoimmune Hypothyroidism in Childhood: A Retrospective Analysis of 256 Cases
    
    hrp0095p1-200
  - Relationships of urinary bisphenol A in childhood on thyroid hormone function in adolescents
    
    hrp0095p1-386
  - Pediatric Graves Disease (PGD): presentation, treatment and follow up. A single center Argentine perspective
    
    hrp0095p1-387
  - Next Generation Sequencing Analysis of Congenital Hypothyroidism Patients in A Single Tertiary Center
    
    hrp0095p1-388
  - Increasing incidence of Pediatric Graves’ Disease
    
    hrp0095p1-389
  - Does serum thyroglobulin predict thyroxine requirement during infancy in athyreosis and thyroid ectopia?
    
    hrp0095p1-390
  - Biochemical Indicators of Euthyroid Sick Syndrome in Critically Ill Children
    
    hrp0095p1-391
  - Clinical Features, Risk Classifications and Long-Term Follow Up Of Childhood Differentiated Thyroid Cancer(DTC): A Single Reference-Center Experience
    
    hrp0095p1-392
  - Urinary Iodine Concentration and Thyroid Function in Children by Age
    
    hrp0095p1-393
  - Analysis on the influencing factors of neonatal serum FT3, FT4 and TSH
    
    hrp0095p1-394
  - The endocrine disruptor cadmium affects both ER[alpha]+ and ER[alpha]- breast cancer cell lines
    
    hrp0095p1-395
  - A rare cause of acquired von Willebrand factor deficiency: Primary hypothyroidism due to autoimmune thyroiditis
    
    hrp0095p1-396
  - Molecular Diagnosis of Non-Autoinmune Subclinical Hypothyroidism in Paediatrics
    
    hrp0095p1-397
  - Unusually Enlarged Ovaries Associated with Severe Hypothyroidism - Van Wyk and Grumbach Syndrome Case Report
    
    hrp0095p1-398
  - Evaluation of Childhood Thyroid Nodules: A Single Center Experience
    
    hrp0095p1-399
  - Total thyroidectomies for endocrinologic indication: Experience in a third level hospital
    
    hrp0095p1-400
  - Newborn screening for congenital hypothyroidism through dried blood spot in Low middle income country (LMIC):experience from a tertiary care center
    
    hrp0095p1-586
  - Sensitivity to Thyroid Hormones and Metabolic Syndrome in Pediatric Patients with Neuromotor Disability
    
    hrp0095p1-587
  - Thyrotoxicosis in children and adolescence in Iceland: A twenty-year retrospective study
    
    hrp0095p1-588
  - Familial Dysalbuminemic Hyperthyroxinemia (FDH) in Asymptomatic Child with High Free T4 and Normal TSH
    
    hrp0095p1-589
  - Immunoglobulin Superfamily 1 (IGSF1) Deficiency: A Rare Cause of Isolated Congenital Hypothyroidism in Two Siblings
    
    hrp0095p1-590
  - Evaluation of Permanent and Transient Congenital Hypothyroidism in Cases Referred from National Neonatal Screening Program
    
    hrp0095p1-591
  - Development of delayed thyrotropin elevation in small-for-gestational-age infants: Is a second screening needed?
    
    hrp0095p1-592
  - Genetic and Functional Studies of Patients with Thyroid Dyshormonogenesis Associated with Defects in The TSH Receptor (TSHR)
    
    hrp0095p1-593
  - Unexpected fast growth velocity in a child with a thyroid hormone receptor beta mutation
    
    hrp0095p1-594
  - Treatment of Graves' Disease in Children and adolecents with Long-Term Antithyroid Drugs: A 20-Year Single-Center Experience
    
    hrp0095p1-595
  - Central and peripheral sensitivity to thyroid hormones and glucose metabolism in childhood obesity
    
    hrp0095p1-596
  - The impact of changes to Joint British Diabetes Societies' diabetes-related ketoacidosis management guidelines on trends of complications and outcome
    
    hrp0095p1-597
  - Retrospective analysis and literature review of five cases of thyroid hormone resistance syndrome caused by THRB gene mutation
    
    hrp0095p1-598
  - Twin pregnancy with a hydatiform mole and coexisting liveborn infant, with maternal hyperthyroidism and neonatal hypothyroidism
    
    hrp0095p1-599
  - Response to Growth Hormone Therapy in Turner And Noonan Syndrome: First Year And Final Height
    
    hrp0095p1-600
- Late Breaking
- - Amenorrhea in an Anorexia Nervosa patient as a presenting symptom of Cushing’s disease
    
    hrp0095lb1
  - Aromatase deficiency due to novel CYP19A1 mutation: A rare cause of maternal virilization and atypical genitalia
    
    hrp0095lb2
  - High Glycated Hemoglobin instead of High Body Mass Index Might Increase the Urine N-acetyl-β-D-glucosaminidase Concentration in Children and Adolescents with Diabetes Mellitus
    
    hrp0095lb3
  - The association between glycated albumin and HbA1c in pediatric acute leukemia patients
    
    hrp0095lb4
  - Incidence and Severity of Type 1 Diabetes Mellitus during COVID-19 Pandemic
    
    hrp0095lb5
  - A case series of two adolescent diabetic siblings due to novel mutation in CFAP126
    
    hrp0095lb6
  - Abstract unavailable
    
    hrp0095lb7
  - Stretched Penile Length Nomogram in Prepubertal Egyptian Children Aged Five to Nine years
    
    hrp0095lb8
  - Prevalence and Factors Associated with Hypothyroidism in Children with Sickle Cell Anemia Aged 6 Months -17 Years Attending the Sickle Cell Clinic, Mulago Hospital, Mg anda; A cross-sectional study
    
    hrp0095lb9
  - Novel CUL3 Variant in Pseudohypoaldosteronism Type 2
    
    hrp0095lb10
  - Cortisol evaluation in 106 neonates born from mothers using corticosteroids during pregnancy. Proposal for practical approach in clinical practice
    
    hrp0095lb11
  - Sleep Quality in Caregivers of Type 1 Diabetes Mellitus Pediatric Patients - The Impact of isCGM Alarms
    
    hrp0095lb12
  - Residual C-peptide secretion and glycemic control in pediatric patients with Diabetes Mellitus type 1
    
    hrp0095lb13
  - A formula to simplify the screening fot impaired glucose tolerance in youths with overweight or obesity
    
    hrp0095lb14
  - Examining Sedentary and Activity Status Predictors in Adolescents and Their Implications for Diabetes Prevention
    
    hrp0095lb15
  - Glucose variability in 6–12-month-old healthy infants
    
    hrp0095lb16
  - Mapping of the current transition of care practice for patients with pituitary disease at Endo-ERN reference centers
    
    hrp0095lb17
  - Efficacy of liquid-chromatography and radioimmunoassay in false-positives’ drop-off in CAH newborn screening
    
    hrp0095lb18
  - The endocrine society practice guideline revisited: why do nowadays patients undergo screening for cushing' syndrome, and with which outcome?
    
    hrp0095lb19
  - Characterization of adrenal miRNA-based dysregulations in Cushing's Syndrome
    
    hrp0095lb20
  - Time from referral to definitive treatment in Cushing's syndrome
    
    hrp0095lb21
  - Mesenchymal Stem Cells exposed to persistently high glucocorticoid levels develop insulin-resistance and altered lipolysis: a promising in vitro model to study Cushing's Syndrome
    
    hrp0095lb22
  - Ten years of growth hormone treatment in children born small for gestational age with persistent short stature- results of a Portuguese multicenter study
    
    hrp0095lb23
  - “Precocious Puberty and Rapidly Progressive Puberty During The Covid-19 Pandemic”
    
    hrp0095lb24
  - Challenges of Gender Assignment in Disorder of Sex Development (DSD) in Developing Countrie
    
    hrp0095lb25
Poster Category 2
- Adrenals and HPA Axis
- - An adrenal enigma: adrenal crises following an acquired CMV infection in an immunocompetent infant
    
    hrp0095p2-1
  - Retrospective cross-sectional study reviewing local practice in assessment of adrenal axis at a tertiary children’s hospital
    
    hrp0095p2-2
  - A Rare Cause of Peripheral Precocious Puberty
    
    hrp0095p2-3
  - The utility of random cortisol in identifying neonatal primary adrenal insufficiency
    
    hrp0095p2-4
  - Prevalence and genotype of 21-hydroxylase deficiency in Croatian Romani population
    
    hrp0095p2-5
  - High carrier frequency of a nonsense p.W230X variant in HSD3B2 gene among Ossetians
    
    hrp0095p2-6
  - Suboptimal cortisol response on ITT and subsequent adrenal insufficiency
    
    hrp0095p2-7
  - An Unusual Case of Histiocytosis Presenting as Bilateral Adrenal Masses
    
    hrp0095p2-8
  - Thrombocytosis as a Rare Manifestation in Salt Wasting Congenital Adrenal Hyperplasia: A Case Report
    
    hrp0095p2-9
  - Long-term Outcomes for Ninety-four Boys with Central Precocious Puberty or Early and Fast Puberty in Chinese Boys
    
    hrp0095p2-10
  - Differences in The Management of Classic Childhood Congenital Adrenal Hyperplasia in Spain According to A Patients Association
    
    hrp0095p2-11
  - Trends in diagnostics and treatment of congenital adrenal hyperplasia
    
    hrp0095p2-12
  - Failure to Thrive As A Manifestation of Neonatal Cushing
    
    hrp0095p2-13
  - The first case of pediatric Cushing disease in Serbia
    
    hrp0095p2-14
  - Congenital hyperreninemic hypoaldosteronism due to aldosterone synthase deficiency
    
    hrp0095p2-15
  - Adrenocortical tumor: a rare tumor in children. Report of 2 infants presented with precocious pubarche and rapid growth
    
    hrp0095p2-16
  - Adrenal Dysfunction in Omani Children Live with Transfusion Dependent Beta-Thalassemia: A Routine Assessment is Recommended
    
    hrp0095p2-17
  - Cushing’s disease treatment results correlation with pituitary MRI in children
    
    hrp0095p2-18
  - A case series on Adrenal Cortical Tumors in Children, Experience from Colombo, Sri Lanka
    
    hrp0095p2-19
  - Panhypopituitarism after treatment procedures in pituitary-hypothalamic area - a single center experience
    
    hrp0095p2-20
  - hrp0095p2-21
  - Two Familial Cases of Congenital Adrenal Hyperplasia Combined or Complicated with Central Precocious Puberty
    
    hrp0095p2-22
  - Primary pigmented nodular adrenocortical disease in a young boy associated with a rare somatic mutation of the PRKACA: case report and literature review
    
    hrp0095p2-23
  - Long-Term Follow-Up of a Case with Clinical Image Syndrome
    
    hrp0095p2-24
  - Genotypic Sex and Severity of the Disease Determine the Time of Clinical Presentation in Steroid 17[alpha]-Hydroxylase/17,20-Lyase Deficiency
    
    hrp0095p2-25
  - 3 β-Hydroxysteroid Dehydrogenase Deficiency, Rare in the Diagnosis of Congenital Adrenal Hyperplasia: A Case Report
    
    hrp0095p2-26
  - It is Not always A Piece of Cake!!
    
    hrp0095p2-27
- Bone, Growth Plate and Mineral Metabolism
- - Longitudinal assessment of bone health index (BHI) as a measure of bone health in short-statured children before and during treatment with recombinant growth hormone
    
    hrp0095p2-28
  - Benign Family Hypercalcemia: A Case Report
    
    hrp0095p2-29
  - Long QT revealing hypoparathyroidism in a B thalassemic major
    
    hrp0095p2-30
  - Short Stature and Single Central Incisor of The Upper Maxillar: Pathogenic Variant in The SHH Gene
    
    hrp0095p2-31
  - A novel pathogenic variant in PLS3 causing severe osteoporosis and vertebral fractures in an adolescent
    
    hrp0095p2-32
  - Maternal Vitamin D deficiency leading to Rickets, Cardiomegaly and Unusual Metabolic Acidosis in a Term Infant: A Case Report
    
    hrp0095p2-33
  - Optimal 25-OH-Vitamin D level in children derived from metabolic parameters
    
    hrp0095p2-34
  - Parathyroid Hormone and Its Relationship to Calcium, Magnesium, and Phosphate in Children age 2 – 5 years old with Abnormal Levels of Vitamin D
    
    hrp0095p2-35
  - A Novel Variant of PHEX in a Korean Family with X-linked Hypophosphatemic Rickets
    
    hrp0095p2-36
  - A rare case of childhood hypophosphatasia presenting with fibrous dysplasia
    
    hrp0095p2-37
  - Addison’s disease: Delay in diagnosis in a girl with longstanding symptoms
    
    hrp0095p2-38
  - An anomalous gait
    
    hrp0095p2-39
  - Overlooking hypoparatahyroidism in an 11-year-old boy patient with CHARGE syndrome
    
    hrp0095p2-40
  - Corticotropin-independent Cushing’s Syndrome in toddlerhood: a challenging diagnosis and treatment
    
    hrp0095p2-41
  - Decreased Vitamin D Levels in The Pediatric Population After Covid-19 Lockdown
    
    hrp0095p2-42
  - Clinical-molecular assistance pathway for primary bone fragility: a pediatric monocentric experience
    
    hrp0095p2-43
  - The changes of body composition in children with obesity
    
    hrp0095p2-44
  - Adult weight and BMI associate with higher bone mineral density in the lumbar spine and femoral neck in young adults born preterm in the surfactant era
    
    hrp0095p2-45
  - Successful treatment with zoledronic acid of a 13-year-old boy with corticosteroid-induced osteoporosis after hematopoietic stem cell transplantation
    
    hrp0095p2-46
  - Severe hypophosphatemia in a girl with vitamin D-dependent rickets type I: a case report
    
    hrp0095p2-47
  - An Unusual Case of Rickets and Anemia Due To Severe Nutritional Deficiency in A Child of Non-Caucasian Ethnicity
    
    hrp0095p2-48
- Diabetes and Insulin
- - A case of diabetes and deafness with heteroplasmic mutations in the mitochondrial DNT1 gene
    
    hrp0095p2-49
  - Inhaled glucagon, a new well-accepted therapeutic tool in pediatrics
    
    hrp0095p2-50
  - Effect of combined hormonal contraceptives use in telomere length and metabolic profile in young women with T1D
    
    hrp0095p2-51
  - Bone and mineral turnover in newly diagnosed children and adolescents with type 1 diabetes mellitus
    
    hrp0095p2-52
  - Clinical and immunological characteristics of new-onset type 1 diabetes in children during the COVID-19 pandemic
    
    hrp0095p2-53
  - Abstract unavailable
    
    hrp0095p2-54
  - A case of de novo ABCC8 gene mutation resulting in Transient Neonatal Diabetes
    
    hrp0095p2-55
  - Monogenic Diabetes (MODY) in Adolescents and Personalized Treatment
    
    hrp0095p2-56
  - Outcome of positive adrenal antibodies identified on screening in children with T1DM
    
    hrp0095p2-57
  - Real-world use of continuous glucose monitoring and its effect on glycemic control among Korean children, adolescents, and young adults with type 1 diabetes
    
    hrp0095p2-58
  - First case of Diabetes Mellitus Caused by compound heterozygous changes in the WFS1 and PTF1A Genes from Kazakhstan
    
    hrp0095p2-59
  - Pediatric Diabetic Ketoacidosis with Hyperosmolarity in Korea: Clinical implications and Outcomes
    
    hrp0095p2-60
  - Ketoacidosis and Age Distribution in New-Onset Type 1 Diabetes During Covid-19 Pandemic
    
    hrp0095p2-61
  - Time Trend and Potential Risk Factors for Celiac Disease Development in Children with Type 1 Diabetes Mellitus-10-year Single Center experience
    
    hrp0095p2-62
  - Atypical diabetes with spontaneous remission associated with systemic lupus erythematosus in an adolescent girl with African ancestry
    
    hrp0095p2-63
  - Diabetes Secondary to Glucokinase Gene Polymorphism with Obesity and Fluctuating Severity of Diabetes
    
    hrp0095p2-64
  - Effect of carbohydrate counting education in Korean patients with type 1 diabetes
    
    hrp0095p2-65
  - A Novel Mutation in the Hepatocyte Nuclear Factor 1-Alpha Detected in Case of a 13-Year-Old Female with Maturity Onset Diabetes of the Young (MODY)
    
    hrp0095p2-66
  - Impact on metabolic control in pediatric patients with use of technology applied to type 1 diabetes
    
    hrp0095p2-67
  - Diabetic Ketoacidosis Resulting From I-port Device Failure In Multiple Cases
    
    hrp0095p2-68
  - Impact of β-cell function and glucose effectiveness on the development of type 2 diabetes mellitus in obese European children and adolescents
    
    hrp0095p2-69
  - Familial Genetic Syndrome of Severe Insulin Resistance and Hyperandrogenemia in a young girl with Polycystic Ovary Morphology
    
    hrp0095p2-70
  - The Effect of Parental Monitoring on Glycemic Control in Adolescents with Type 1 Diabetes
    
    hrp0095p2-71
  - A rare case of Type 1 Diabetes preceded by Hashimoto thyroiditis and followed by Multiple Sclerosis
    
    hrp0095p2-72
  - Recurrent glycogenic hepatopathy in an 11-year-old boy with poor glycemic controlled type 1 diabetes mellitus
    
    hrp0095p2-73
  - Knowledge and Confidence of Omani Paediatric Residents in Managing Diabetic Ketoacidosis (DKA); A Cross Sectional Survey
    
    hrp0095p2-74
  - Low vitamin D levels are associated with markers of metabolic syndrome in children with newly onset type 1 diabetes mellitus
    
    hrp0095p2-75
  - Fibroblast growth factor 23 in relation to calcium-phosphate metabolism and cardiovascular risk factors in patients with type 1 diabetes.
    
    hrp0095p2-76
  - Rituximab Role in Preservation of Pancreatic Beta Cells in Patients Newly Diagnosed With Type 1 Diabetes Mellitus: A Report of 2 Palestinian Cases
    
    hrp0095p2-77
  - Complications of Covid-19 on the thyroid gland functioning
    
    hrp0095p2-78
  - Association of type 1 diabetes mellitus with autoimmune diseases in children in the Department of Endocrinology-Diabetology and Nutrition at Mohammed VI University Hospital Center Oujda
    
    hrp0095p2-79
  - A MODY2 pedigree with GCK gene mutation and literatures review
    
    hrp0095p2-80
  - Steroid-induced diabetes mellitus in children and adolescents: risk factors, course features, treatment specifics and prognosis on example of 10 patients
    
    hrp0095p2-81
  - An unusual combination: Wolfram Syndrome Type 1 with type-1-Diabetes mellitus
    
    hrp0095p2-82
  - Arterial Hypertension and Insulin-Dependent Diabetes : Experience Of The Consultation at The Children’s Hospital In Rabat
    
    hrp0095p2-83
  - Assessment of serum concetrations of decorin, vaspin and kallistatin in children with type 1 diabetes
    
    hrp0095p2-84
  - Growth Monitoring in children With Type 1 Diabetes: A Single Center Experience
    
    hrp0095p2-85
  - Type 1 diabetes in children: What are the particularities?
    
    hrp0095p2-86
  - 100 years with insulin. Implementation of analogs and technology in our environment
    
    hrp0095p2-87
  - Association of type 1 diabetes mellitus with autoimmune diseases in children in the Department of Endocrinology-Diabetology and Nutrition at Mohammed VI University Hospital Center Oujda
    
    hrp0095p2-88
  - Design, certification and evaluation of an Insulin Infusion Therapy Care and Education Program (PAETII) in children/adolescents in a Pediatric Unit.
    
    hrp0095p2-89
  - Contribution of 25 Hydroxy Vitamin D to the Risk of Development of Type 1 Diabetes in Children
    
    hrp0095p2-90
  - Presentation of Newly Diagnosed Type1 Diabetes Mellitus
    
    hrp0095p2-91
- Fat, Metabolism and Obesity
- - Different profiles of lipoprotein particles associate various degree of cardiac involvement in adolescents with morbid obesity
    
    hrp0095p2-92
  - The Relationship Between Serum AMH Levels and Puberty in Obese Girls
    
    hrp0095p2-93
  - Liraglutide associated with a multidisciplinary program for the treatment of adolescents obesity in a low income setting: a real life experience
    
    hrp0095p2-94
  - Effect of cholecalciferol treatment on serum FGF-23, vitamin D-binding globulin and [alpha]-klotho levels in children with vitamin D deficiency
    
    hrp0095p2-95
  - SGPT and FT4 correlations among Greek school age children with obesity or severe obesity
    
    hrp0095p2-96
  - Linear growth and prevalence of the different components of the metabolic syndrome (MetS) in young obese nondiabetic children (below 5 years) in comparison to older obese children (6-12 years)
    
    hrp0095p2-97
  - Effects of long-term metreleptin replacement therapy on weight and comorbidities in a patient with bioinactive leptin
    
    hrp0095p2-98
  - Gender differences in Italian pediatric obese subjects
    
    hrp0095p2-99
  - Comparison between Triglyceride-Glucose Index (TyG) and Atherogenic index of plasma (AIP) in relation to the different components of the metabolic syndrome (MetS) in morbidly obese children
    
    hrp0095p2-100
  - Epicardial fat, interventricular septal and leftventricular posterior wall thicknesses are associated with cardiometabolic risk markers and physical activity in apparently healthy school-age children
    
    hrp0095p2-101
  - Long term effect of metformin therapy in children and young people with obesity - A single center experience
    
    hrp0095p2-102
  - Reduction of The Nutritional Diagnosis of Eutrophy Among Brazilian Adolescents, Evaluation From 2010 to 2021
    
    hrp0095p2-103
  - Leptinemia and cardiometabolic risk factors in genetic obesity syndromic in children : Prader Willi and Bardet Biedl
    
    hrp0095p2-104
  - A Comprehensive Multidisciplinary Management Plan Is Effective in Reducing the Prevalence of Overweight and Obesity in Adolescence
    
    hrp0095p2-105
  - Identification of a novel point mutation in APOB gene in a patient with hypobetalipoproteinemia
    
    hrp0095p2-106
  - An Obese Patient with A Pathogenic PTEN Mutation. A Case Report
    
    hrp0095p2-107
  - A Noval De Novo PHIP Variant Contributing to Chung-Jansen Syndrome: a case report and review
    
    hrp0095p2-108
  - Updated reference ranges for aminotransferase levels of Korean children and young adolescents based on the risk factors for metabolic syndrome
    
    hrp0095p2-109
  - Uric Acid as A Marker of Cardiovascular Risk and Insulin-Resistance in Course of Pediatric Obesity
    
    hrp0095p2-110
  - Gamma-Glutamyl Transferase (GGT) and The GGT / High-Density Lipoprotein (HDL) Ratio: Useful Tools for Identification of OBESE Children with Insulin Resistance
    
    hrp0095p2-111
  - Prediabetes in Obesity Adolescents: Frequency, Structure, Relationship with Body Mass Index
    
    hrp0095p2-112
  - Binge eating disorder in children with different forms of obesity
    
    hrp0095p2-113
  - Leptin receptor deficiency: a case report
    
    hrp0095p2-114
  - Is it Hyponatremia or Pseudohyponatremia? Management of Low Serum Sodium in Patient with Acute Pancreatitis Secondary to Hypertriglyceridemia
    
    hrp0095p2-115
  - Abstract unavailable
    
    hrp0095p2-116
  - Cardiometabolic risk factor clustering in obese adolescents
    
    hrp0095p2-117
  - Relationship Between Neck Circumference and Cardiometabolic Risk in Children and Adolescents with Obesity
    
    hrp0095p2-118
  - Abstract unavailable
    
    hrp0095p2-119
  - Evaluation of Thyroid Function among children and adolescents with obesity
    
    hrp0095p2-120
  - Age-related cardiometabolic risk in children and adolescents
    
    hrp0095p2-121
  - Pediatric Endocrine evaluation of Marfan syndrome: A case report
    
    hrp0095p2-122
  - Diagnosis and management of childhood obesity during COVID-19 pandemic: an audit on clinical practice in a tertiary center
    
    hrp0095p2-123
  - hrp0095p2-124
  - Effects of confinement due to COVID-19 in the child population of Álava on vitamin D status
    
    hrp0095p2-125
  - Vitamin D, OPG in Obese Children
    
    hrp0095p2-126
  - The effects of Long-term (five years) Prednisone Therapy in Frequently Relapsing Nephrotic Syndrome of Childhood: Impact on glycemia and the different components of the metabolic syndrome (MetS)
    
    hrp0095p2-127
- Fetal, Neonatal Endocrinology and Metabolism
- - Placental Weight and their relation to Infant Birth weight and Gender, Gestational Age, and Maternal Age: (A Population-Based Retrospective Data Analysis (n = 80722)
    
    hrp0095p2-128
  - Molecular pathways linking fetal growth restriction to cardiometabolic risk in childhood
    
    hrp0095p2-129
  - Postnatal Growth in Infants of Diabetic Mothers (IDM) (n = 79) Who Were Born at or Near Term and Had Severe Neonatal Hypoglycemia Without Other Comorbidities
    
    hrp0095p2-130
  - Small for Gestational Age (SGA) Babies Identified Through in the Pilot Programme for Early Detection and Follow-Up of SGA Children
    
    hrp0095p2-131
  - Hyperinsulinaemic Hypoglycaemia – are neonates symptomatic during hypoglycaemia?
    
    hrp0095p2-132
  - Hypoglycemia as a result of growth hormone deficiency and Glycogen storage disease type 0a in a patient with short stature – case report
    
    hrp0095p2-133
  - Neonatal hypoglycemia in infants of diabetic mothers vs infants of non-diabetic mothers in relation to birth weight
    
    hrp0095p2-134
  - Incidence of neonatal hypoglycemia in Qatar: A 3-year study
    
    hrp0095p2-135
  - Growth patterns in Infants with Significant Neonatal Hypoglycemia during the first two years of age: Comparison of infants of Diabetic Mothers (IDM) vs infants of non-diabetic mothers (INDM)
    
    hrp0095p2-136
  - Relationship Between Birth Body Weight≪10.Th Centile (Sga) And Insulin-Like Growth Factor Binding Protein-2 / Insulin-Like Growth Factor Binding Protein-3 Ratio In The Not-Life Threatened Newborn: Relevance Of Birth Chest Circumference / Birth Body Wei
    
    hrp0095p2-137
  - Hypoglycemia in children: Clinical experience of a tertiary care center
    
    hrp0095p2-138
  - A stormy neonatal course
    
    hrp0095p2-139
  - POU1F1 gene mutation as a cause of central hypothyroidism and growth hormone deficiency: a case report
    
    hrp0095p2-140
  - Relationship Between Birth Body Weight<10.TH Centile (SGA) and Insulin-Like Growth Factor-I in The Not-Life Threatened Newborn: Relevance of Birth Chest Circumference / Birth Body Weight Ratio
    
    hrp0095p2-141
  - Case Report of an Infant with Severe Symptomatic Hypoglycemia and A Rare ABCC8 Gene Mutation Inherited from his Unaffected Father and A Focal form of Hi
    
    hrp0095p2-142
  - All Roads Don’t Lead to Rome After All!!
    
    hrp0095p2-143
- GH and IGFs
- - Growpati Study: Clinical and genetic characterization of a cohort of patients with short stature due to severe primary IGF1 deficiency
    
    hrp0095p2-144
  - A user-centred approach to improve digital health solutions in patients requiring growth hormone therapy: Results of a participatory workshop
    
    hrp0095p2-145
  - GH responsiveness and IGF1 P2 promotor methylation
    
    hrp0095p2-146
  - Perception of long-acting growth hormone- data from two surveys in Austria
    
    hrp0095p2-147
  - Height Velocity in Indonesian Children Receiving Growth Hormone Therapy
    
    hrp0095p2-148
  - Advancing personalised medicine for growth hormone delivery: mixed-methods participatory study of a next generation, smart auto-injector device
    
    hrp0095p2-149
  - Alterations in stem cell populations during rIgF-1 (Increlex) therapy in patients with SPIGF1D
    
    hrp0095p2-150
  - A novel mutation of LHX3 is associated with combined hypopituitarism and dysmorphic face
    
    hrp0095p2-151
  - IGF1 as reassessment method of GH deficiency in adulthood
    
    hrp0095p2-152
  - Avascular necrosis of the hip as a rare complication of growth hormone therapy
    
    hrp0095p2-153
  - Predictive Factors of Adult Height After 2 Years of GH Replacement Therapy in Children with Growth Hormone Deficiency (GHD)
    
    hrp0095p2-154
  - Poor efficacy of growth hormone treatment in a patient with fetal alcohol syndrome
    
    hrp0095p2-155
  - Short Term Effects of Growth Hormone in Children and Adolescents with Growth Hormone Deficiency
    
    hrp0095p2-156
  - Prevalence of Childhood Short Stature and weight variations Among Primary School Children
    
    hrp0095p2-157
- Growth and Syndromes
- - Global recall of a growth hormone jet delivered device: experiences with children forced to switch from a needle free system to a growth hormone device with needle
    
    hrp0095p2-158
  - SHOX haploinsufficiency among patients with idiopathic short stature
    
    hrp0095p2-159
  - HbA1C stability - is posting samples reliable?
    
    hrp0095p2-160
  - Noonan syndrome-like disorder with loose anagen hair (NSLH1): watch out for the red hair
    
    hrp0095p2-161
  - Long term effect of growth hormone treatment in a patient with growth hormone deficiency and mitochondrial disease due to TMEM70 gene mutation
    
    hrp0095p2-162
  - Beckwith-Wiedemann Syndrome: Two Familial Cases with CDKN1C gene variants
    
    hrp0095p2-163
  - Growth of extremely low birth weight infants (ELBW) at a tertiary hospital: catch-up growth continues during the 3rd year of life
    
    hrp0095p2-164
  - Postnatal growth in Preterm infants as a function of their weight for gestational age (GA) (WAZ) at birth: Comparison between those who were born underweight (WAZ <-2) compared to those with normal weight (WAZ > -2)
    
    hrp0095p2-165
  - Postnatal growth in Preterm infants as a function of their head size (head circumference Z score (HCZ) at birth: Comparison between those who were with a large head (HCZ <-2) to those with normal Head size for gestational age (HCZ > -2)
    
    hrp0095p2-166
  - Short stature and mild developmental delay in a child with partial duplication of DIAPH2 gene: good response to recombinant Growth Hormone therapy: A Case Report
    
    hrp0095p2-167
  - Two siblings whose differential diagnosis with rickets; Schmid Metaphyseal Chondrodysplasia
    
    hrp0095p2-168
  - Response to Treatment with Recombinant Growth Hormone in Children and Adolescents with Short Stature Associated with Noonan Syndrome
    
    hrp0095p2-169
  - A rare case of a child with Type 1 diabetes who was subsequently diagnosed with both growth hormone deficiency and Turner Syndrome
    
    hrp0095p2-170
  - Case report of a child with cerebellar-facial-dental syndrome and multiple coexisting genetic
    
    hrp0095p2-171
  - Practicability and user friendliness of height measurement by proof of concept APP using Augmented Reality, in 22 healthy children
    
    hrp0095p2-172
  - Case report of Leprechaunism syndrome in an Algerian child
    
    hrp0095p2-173
  - Lysine urinary protein intolerance with lupus kidney, lupus brain and extremely short stature: a case report and literatures review
    
    hrp0095p2-174
  - Central Hypothyroidism as a manifestation of X linked IGSF1 Deficiency Syndrome: a case report
    
    hrp0095p2-175
  - A case of 1q21 recurrent microdeletion syndrome with growth hormone deficiency, facial dysmorphism, and microcephaly
    
    hrp0095p2-176
  - Effects of Somatropin treatment in different groups of patients with indication for replacement therapy: isolated growth hormone deficiency, small for gestational age, Turner syndrome and Prader-Willi syndrome
    
    hrp0095p2-177
  - A Rare Cause of Proteinuria Presenting with Short Stature, Cataract, and Dysmorphic Findings: Lowe Syndrome with A Novel de Novo Mutation in the OCRL1 Gene
    
    hrp0095p2-178
  - The syndrome behind the short stature! The difficult approach in Turner Syndrome with Y-chromosome sequences present
    
    hrp0095p2-179
  - Beckwith-Wiedemann Syndrome: three case reports
    
    hrp0095p2-180
  - IHH gene variant causing short stature and minor skeletal disorders
    
    hrp0095p2-181
  - Persistent leukocytosis in a Noonan syndrome-neurofibromatosis type 1 patient treated with recombinant human growth hormone
    
    hrp0095p2-182
  - First Korean case of a novel ZC4H2 mutation in Wieacker-Wolff syndrome with recurrent hypoglycemia
    
    hrp0095p2-183
  - Clinical characteristics and genetic analysis of BLM gene mutation with Bloom syndrome without facial erythema changes
    
    hrp0095p2-184
  - Coexistence of (likely) pathogenic variants in two genes, EZH2 and PTEN, contribute to overgrowth and developmental delay phenotype in a female patient
    
    hrp0095p2-185
  - Effect of Growth Hormone Therapy on Height in Children: Idiopathic Gh Deficient, Family Short Stature, Small for Gestational Age
    
    hrp0095p2-186
  - Combination Down / Klinefelter syndrome - a Clinical Case
    
    hrp0095p2-187
  - Kearns-Sayre syndrome – a rare cause of growth hormone deficiency
    
    hrp0095p2-188
  - Does she need growth hormone treatment?
    
    hrp0095p2-189
  - Results of treatment with recombinant human growth hormone (rhGH) in patients with Turner syndrome. Albanian experience
    
    hrp0095p2-190
  - A case report of gonadal Y-chromosome mosaicism 45, X Turner syndrome complicated by HCG-secreting gonadoblastoma
    
    hrp0095p2-191
  - Acromelic dysplasia: a case report
    
    hrp0095p2-192
  - Spontaneous final adult height in patients with idiopathic short stature
    
    hrp0095p2-193
  - Growth hormone deficiency and SHOX variants present in 2 siblings short for the family target
    
    hrp0095p2-194
  - Syndromic Disorders with Short Stature
    
    hrp0095p2-195
  - A retrospective analysis of short stature patients in the pediatric department of CHU Mustapha Pacha, Algeria between 2014 and 2022
    
    hrp0095p2-196
  - Characterization of A Patient with "Rasopathies" Type of Noonan Syndrome Due to Mutation of PTPN11 in A Pediatric Endocrine Consultation
    
    hrp0095p2-197
  - Efficacity of Growth Hormone Treatment in Children with Intrauterine Growth Restriction IUGR
    
    hrp0095p2-198
  - Challenges of late diagnosis of turner's syndrome: a case report of 18 women
    
    hrp0095p2-199
  - Growth of children with cow milk allergy on the elimination diet
    
    hrp0095p2-200
  - Association between Turner Syndrom and GH deficiency: 04 case
    
    hrp0095p2-201
- Multisystem Endocrine Disorders
- - AgRP neurons mediate sex differences in response to the activity-based anorexia model
    
    hrp0095p2-202
  - A Case of SHOX Deletion Due to Isodicentric Y Chromosome Anomaly with Multiple Endocrine Disorders
    
    hrp0095p2-203
  - Early detection of gastrointestinal polyps and neoplasia following radiation for childhood-onset cancer
    
    hrp0095p2-204
  - A novel mutation of AIRE gene in a patient with Autoimmune Polyglandular Syndrome type I (APS1), a case report
    
    hrp0095p2-205
  - Rare association of hyperinsulinemic hypoglycemia in a pediatric patient with oculofaciocardiodental syndrome and mother with neuroendocrine pancreatic tumor
    
    hrp0095p2-206
  - Restriction of physical activity is the main cause of childhood obesity during the COVID-19 pandemic - reflections from a study conducted in 3 clinical centers in southern Poland
    
    hrp0095p2-207
  - Precocious puberty before and after the COVID-19 pandemic
    
    hrp0095p2-208
  - Fahr's syndrome in children: About 2 cases
    
    hrp0095p2-209
  - Glucose dysregulation and Diabetes mellitus in ROHHAD syndrome - possibly centrally driven?
    
    hrp0095p2-210
  - McCune Albright Syndrome in children- Case series from a Tertiary Care Centre- Sri Lanka
    
    hrp0095p2-211
  - Endocrinological Evaluation in a Case with WAGR Syndrome
    
    hrp0095p2-212
  - and endocrine characteristics of Algerian children with McCune -Albright Syndrome: Clinical
    
    hrp0095p2-213
- Pituitary, Neuroendocrinology and Puberty
- - Central precocious puberty - an unusual paraneoplastic manifestation of a nephroblastoma?
    
    hrp0095p2-214
  - Congenital Hypopituitarism and Diabetes Insipidus with Normal Radiological Pituitary Gland and a Mutation in IRF2BPL
    
    hrp0095p2-215
  - β-hcg secreting intracranial germinoma in a girl with isosexual precocious puberty : A case report and review of literature
    
    hrp0095p2-216
  - A rare case of Cystic fibrosis and Pallister-Hall syndrome combination in a 3-year-old boy
    
    hrp0095p2-217
  - Evaluation of The Effects of Carob (Ceratonia Siliqua L.) Fruits on the Puberty of Rats
    
    hrp0095p2-218
  - Central diabetes insipidus in children – analysis of the different clinical picture
    
    hrp0095p2-219
  - Pituitary Macroadenomas in Childhood and Adolescence. Clinical Analysis of 7 Cases
    
    hrp0095p2-220
  - [ldquo]Sleep Properly, Reduce Intake, aNd Get Stepping[rdquo] (SPRINGS): a multidisciplinary approach to managing paediatric morbid obesity with severe obstructive sleep apnoea
    
    hrp0095p2-221
  - A rare case of Langerhans cell histiocytosis of the central nervous system in a child
    
    hrp0095p2-222
  - Double Pituitary gland-pulse syndrome ((DPG)-plus syndrome) and idiopathic infantile hypercalcemia: a combination of rare disorders- Case report and review of literature
    
    hrp0095p2-223
  - Case Report of Familial X-Linked Hypopituitarism, without Confirmed Genetic Mutation
    
    hrp0095p2-224
  - Clinical Characters and Prognosis of a Case With Bifocal Germ Cell Tumors in Children
    
    hrp0095p2-225
  - Polyuria-polydipsia- first sign of a rare hematological disease
    
    hrp0095p2-226
  - Growth Hormone Deficiency in A Boy with Duplication 5q35.2q35.3
    
    hrp0095p2-227
  - Infection with SARS-CoV-2 may alter the half-life of desmopressin (DDAVP) in children with central diabetes insipidus
    
    hrp0095p2-228
  - 12 years follow-up of GH/PRL secreting pituitary macroadenoma in a child with McCune Albright syndrome
    
    hrp0095p2-229
  - Pituitary stalk interruption syndrome presenting with catch up of growth
    
    hrp0095p2-230
  - Epidemiological characteristics, treatment and its outcomes in children presenting with Craniopharyngioma at a tertiary care center
    
    hrp0095p2-231
  - Clinical and Para Clinical Features, Effect Oftriptoreline 11.25 Mg Every 3 Months in Patients with Central Precocious Puberty After 6 Months of Treatment
    
    hrp0095p2-232
  - Central precocious puberty in a girl with vasculitis-related moyamoya syndrome
    
    hrp0095p2-233
  - Management of precocious puberty in girls with McCune–Albright syndrome
    
    hrp0095p2-234
  - Precocious puberty revealing a McCune Albright syndrome: About a case
    
    hrp0095p2-235
  - Challenges in The Era of Covid-19: Starting from The Clinical Examination
    
    hrp0095p2-236
  - Gigantism and Central Precocious Puberty in Egyptian Female Pediatric Patient due to benign Pituitary gland Hyperplasi
    
    hrp0095p2-237
  - Rare causes of hypopituitarism in children
    
    hrp0095p2-238
  - Interest of LHRH test in the exploration of precocious pubert
    
    hrp0095p2-239
  - Report of a case of central precocious puberty in girls associated with pilocytic astrocytoma
    
    hrp0095p2-240
  - Primary polydipsia in a male adolescent
    
    hrp0095p2-241
  - McCune-Albright Syndrome : knowing how to think about it
    
    hrp0095p2-242
  - Delayed puberty by anomalies hypo-gonadotropic hypogonadism, hyper-gonadotropic hypogonadism and puberty induction
    
    hrp0095p2-243
  - Congenital Hypopituitarism : a pathology not to be ignored
    
    hrp0095p2-244
  - To give or not to give GnRH agonists in central precocious puberty due to pituitary microadenoma?
    
    hrp0095p2-245
  - Massive Open Online Learning - accelerating knowledge in digital health in the management of children with growth disorders
    
    hrp0095p2-246
  - A girl with concurrent congenital adrenal hyperplasia, isolated growth hormone deficiency type II (IGHD II) and a new mutation in the GH 1 gene - an extremely unusual case
    
    hrp0095p2-247
  - McCune-Albright Syndrome : knowing how to think about it
    
    hrp0095p2-248
- Sex Differentiation, Gonads and Gynaecology, and Sex Endocrinology
- - 5 Alpha Reductase Deficiency as the Etiology of Primary Amenorrhea in a Girl with Thalassemia Major
    
    hrp0095p2-249
  - Clinical case: Diagnostic / therapeutic procedure of a 46,XY complete gonadal dysgenesis
    
    hrp0095p2-250
  - Clinical and Ultrasound Diagnosis of A Complicated Giant Ovarian Teratoma
    
    hrp0095p2-251
  - Premature ovarian failure in two female patients with 47, XXX karyotype
    
    hrp0095p2-252
  - Clinical characteristic and testicular function in children with 46 XY disorder of sex development in a developing country
    
    hrp0095p2-253
  - Intracranial beta human chorionic gonadotropin(β-hCG)-secreting germ cell tumor in a girl with central precocious puberty
    
    hrp0095p2-254
  - Expression of Adam and Adamts Proteases Following Currative GnRHa Treatment for Cryptorchidism
    
    hrp0095p2-255
  - Case report: Roumanian baby with cytochrome P450 oxidoreductase deficiency
    
    hrp0095p2-256
  - A Novel Discovered Role for CFTR in Azoospermia and Wolffian Duct Maldevelopment Caused by CryptorchidismA Novel Discovered Role for CFTR in Azoospermia and Wolffian Duct Maldevelopment Caused by CryptorchidismA Novel Discovered Role for CFTR in Azoospermia and Wolffian Duct Maldevelopment Caused by CryptorchidismA Novel Discovered Role for CFTR in Azoospermia and Wolffian Duct Maldevelopment Caused by Cryptorchidism
    
    hrp0095p2-257
  - Comparative characterization of hypogonadotropic hypogonadism and constitutional delayed puberty in girls
    
    hrp0095p2-258
  - A case of 46, XX female with short stature, primary ovarian insufficiency and kidney dystopia due to two novel mutations in MCM8 gene
    
    hrp0095p2-259
  - Analysis of the spectrum of disorders of sex development in Diabetes, Endocrine and Metabolism Pediatric Unit, Cairo University, Egypt
    
    hrp0095p2-260
  - VSD genetic diagnosis exploiting single-cell expression data and deep learning
    
    hrp0095p2-261
  - Analyze of clinical, biological and therapeutic aspects of 46 XY DSD
    
    hrp0095p2-262
  - Complete Androgen Insensitivity Syndrome: a case report
    
    hrp0095p2-263
  - StAR gene mutation : description of puberty development and genital life from 6 patients 46,XX with classic Congenital Lipoid Adrenal Hyperplasia
    
    hrp0095p2-264
  - Gynecomastia and Short Height;45,X[2]/ 46,X, +mar[28] karyotype
    
    hrp0095p2-265
  - From urine progenitor cells to induced pluripotent stem cells
    
    hrp0095p2-266
  - Gonadal Dusfunction in Polytransfused Beta-Thalassemia Patients
    
    hrp0095p2-267
  - Case Report:Clinical and genetic features of 46, XY DSD caused by a mutation in DHX37 gene
    
    hrp0095p2-268
  - A Case of Under virilized Male with 18q Partial Monosomy and 10p Duplication
    
    hrp0095p2-269
  - What lessons from past history of patients with CAH in a Sub Saharan country?
    
    hrp0095p2-270
  - Wide phenotypical spectrum with the same karyotype: Mixed gonadal dysgenesis
    
    hrp0095p2-271
  - A Rare HSD17B3 Gene Variant Presenting Virilization at Puberty: Management and Treatment in Adolescent Age
    
    hrp0095p2-272
  - Isodicentric Y Chromosomes in Patients with Disorders of Sex Development
    
    hrp0095p2-273
  - Congenital hypogonadotropic hypogonadism caused by a novel mutation of GnRHR gene: a case report
    
    hrp0095p2-274
  - A female with 46,XX gonadal dysgenesis presenting with hypergonadotropic hypogonadism and normal height
    
    hrp0095p2-275
  - The challenge of gender identity due to 5α-reductase deficiency- a case report
    
    hrp0095p2-276
  - Study of the epidemiological, clinical and metabolic markers during an anomaly of sexual differentiation in children
    
    hrp0095p2-277
  - Delayed puberty by anomalies hypo-gonadotropic hypogonadism, hyper-gonadotropic hypogonadism and puberty induction
    
    hrp0095p2-278
- Thyroid
- - Evaluating the role of circulating dendritic cells in methimazole-treated pediatric Graves’ disease patients
    
    hrp0095p2-279
  - From overt hyperthyroidism to normal thyroid function in TSH receptor activating mutations: reports of two families with novel pathogenetic variants and suggestion of a phenotypical sexual dimorphism
    
    hrp0095p2-280
  - Effects of therapy on Th1, Th17, Th22 and Bregs in pediatric patients with Graves' disease
    
    hrp0095p2-281
  - Papillary Tyhroid Carcinoma in Two Siblings With Congenital Famial Hypothyroidism
    
    hrp0095p2-282
  - Identification of Predictors of Transient and Permanent Congenital Hypothyroidism
    
    hrp0095p2-283
  - Prevalence of pediatric thyroid cancer in Latvia
    
    hrp0095p2-284
  - COVID 19 impact on Pediatric Endocrinology care - a short story from Romania
    
    hrp0095p2-285
  - A Case of Sjogren's Syndrome with systemic involvement combined with exacerbated hyperthyroidism improved after glucocorticoid treatment
    
    hrp0095p2-286
  - Prader Willi Syndrome with Cribiform Papillary Thyroid Carcinoma. A case to share
    
    hrp0095p2-287
  - Comorbidities in Turner Syndrome patients controlled in our center since the 80’s
    
    hrp0095p2-288
  - Retrospective assessment of malignant thyroid nodules in a group of polish children and adolescents involving elastography
    
    hrp0095p2-289
  - Acquired Hypothyroidism in Children: Hypertrichosis as unusual presentation. A Case Report
    
    hrp0095p2-290
  - Graves' disease outcome in children and adolescents
    
    hrp0095p2-291
  - Assessment of thyroid function in steroid resistant nephrotic syndrome patients
    
    hrp0095p2-292
  - The importance of thyroid function tests in precocious menarche: Van Wyk Grumbach syndrome
    
    hrp0095p2-293
  - Hypothyroidism presenting with left sided Brown’s syndrome
    
    hrp0095p2-294
  - Girl with thyroid hormone resistance: a case report
    
    hrp0095p2-295
  - Factors related to permanent congenital hypothyroidism
    
    hrp0095p2-296
  - Discrimination between transient and permanent congenital hypothyroidism in patients with eutopic thyroid gland
    
    hrp0095p2-297
  - Complicated Hypothyroidism in a Child with Trisomy 21
    
    hrp0095p2-298
  - Chronic urticaria associated with Hashimoto’s thyroiditis : A case report
    
    hrp0095p2-299
  - Thyroid Function and Congenital Heart Defects in Children with Down Syndrome at Hasan Sadikin General Hospital, Bandung, Indonesia
    
    hrp0095p2-300
- Late Breaking
- - Analysis of Factors Affecting Bone Mineral Density in Children and Adolescents with systemic lupus erythematosus
    
    hrp0095p2-301
  - Pseudohypoparathyroidism- Presented with a convulsion
    
    hrp0095p2-302
  - Donohue syndrome in a Turkish infant: Mild clinical course despite severe genetic mutation
    
    hrp0095p2-303
  - Diabetic ketoacidosis associated with hypertriglyceridemia in the pediatric age group – A case report
    
    hrp0095p2-304
  - Poor Infant Feeding Practices and Type 1 Diabetes Mellitus: Any Correlation?
    
    hrp0095p2-305
  - Clinical Spectrum of Associated Autoimmune Conditions in Children with Type 1 Diabetes Mellitus (TIDM) in Developing Countries
    
    hrp0095p2-306
  - Hypoglycemia as a result of skewed thiopurine metabolism in two pediatric patients
    
    hrp0095p2-307
  - Lal-D: Know it To Recognize it
    
    hrp0095p2-308
  - Three cases of Latent Autoimmune Diabetes in Youth in Korean Obese Adolescents
    
    hrp0095p2-309
  - GH Treatment in A Girl with Acrodysostosis Type 2 Due to Novo Mutation in PDE4D gene
    
    hrp0095p2-310
  - A novel 2q12 duplication causes intellectual disability and short stature in a Turkish family
    
    hrp0095p2-311
  - Karyotype-phenotype correlation and associated problems in patients with Turner Syndrome: a single center Turkish experience
    
    hrp0095p2-312
  - A rare cause of precocious puberty: Hepatoblastoma
    
    hrp0095p2-313
  - A case of permanent congenital hypothyroidism with NKX2-1 mutation and optic nerve thickness
    
    hrp0095p2-314

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more

ESPE Abstracts

60th Annual ESPE (ESPE 2022)

Contents

BiosciAbstracts